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ABSTRACT 
Traumatic spinal cord leads to devastating and permanent loss of neurological function. 
Artificial tissue engineering scaffolds show potential in spinal cord repair by providing guidance 
for regrowing axons. In this study, three-dimensional (3D) alginate/hyaluronic acid scaffolds 
designed for spinal cord repair were fabricated and characterized. Specifically, covalently and 
ionically crosslinked alginate/hyaluronic acid composite biomaterial was used for Schwann cell 
culture and for 3D scaffold fabrication and characterization. Carbodiimide mediated amide 
formation of composite biomaterial was examined in presence of ionic crosslinking and was 
found to be dependent on the concentrations of carbodiimide and calcium chloride and on the pH 
value of the reaction. The double-crosslinked composite hydrogels were biocompatible, allowing 
for Schwann cell survival and growth. No significant difference in cell number was found on the 
composite hydrogels with varying concentrations of alginate and hyaluronic acid used in this 
study. The results also indicated that covalent crosslinking and high concentration of hyaluronic 
acid were not favorable for Schwann cell growth. Finally, 3D porous scaffolds were successfully 
fabricated using two systems of the dispensing-based rapid prototyping technique. Effects of the 
fluid behavior, initial needle height, and concentration of calcium chloride were studied. 
Uniaxial compression mechanical test showed that the concentration of hyaluronic acid had little 
effect on the mechanical properties of the hydrogels, and that ionically crosslinked composite 
hydrogels had a similar viscoelastic compressive behavior as native spinal cord and had Young’s 
moduli favorable for neurite outgrowth. This information provides a basis for continuing in vitro 
and in vivo tests of the ability of rapid prototyped alginate/hyaluronic acid hydrogel scaffolds to 
support regeneration of traumatic spinal cord.   
 III 
ACKNOWLEDGMENTS 
Here I want to extend my most sincere appreciation to my two supervisors, Dr. Daniel 
Chen and Dr. David Schreyer. Their expertise, encouragement, patience and enthusiasm for 
knowledge impressed me so much and guided me through all the difficulties and challenges 
occurring in my research projects. I will always be grateful for their supervision.  
 
Also, I would like to thank my Advisory Committee members, Dr. Ildiko Badea and Dr. 
Chris Zhang for their kind examination and advices on my research work.  
 
I also want to express my gratitude to Dr. Ian Burgess (Department of Chemistry) and Dr. 
Catherine Niu (Department of Chemical Engineering) for providing me with valuable comments 
and research instruments. Such research technicians as Tangyne Berry, Doug Bitner, Ruiling 
Zhai, Pia Wennek, Rob Piece and Natasha Vetter have provided me with lots of technical 
support for my experiment, without which I could not have finished my research work.  
 
Special thanks are given to the students in the Tissue Engineering Research Group and 
other department including Peng Zhai, Minggan Li, Ning Zhu, Ning Cao, Haidong Wang, 
Zhiming Zhang, Wenbin Zhang, Nahshon Bawolin, Ajay Rajaram, Chenglin Liu, Xiaoyu Tian, 
Xin Yan, Li Zhou, and Huishu Hou.  
 
I would also like to acknowledge the support of a scholarship from the College of 
Graduate Studies and Research of the University of Saskatchewan and of research funding from 
the Canadian Institutes of Health Research (CIHR). 
 IV 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
DEDICATED TO MY GRANDPARENTS AND PARENTS
 V 
TABLE OF CONTENTS 
                                                                                                                                                    Page 
ABSTRACT .............................................................................................................................. II 
ACKNOWLEDGMENTS ......................................................................................................... III 
TABLE OF CONTENTS ........................................................................................................... V 
LIST OF TABLES ................................................................................................................. VIII 
LIST OF FIGURES ................................................................................................................. IX 
LIST OF ABBREVIATIONS.................................................................................................. XII 
CHAPTER 1 Introduction and Objectives ...................................................................................1 
1.1 SPINAL CORD INJURY .................................................................................................................... 1 
1.1.1 Organization of Spinal Cord ................................................................................................... 1 
1.1.2 Spinal Cord Injury .................................................................................................................. 3 
1.1.3 Therapeutic Strategies for Spinal Cord Repair......................................................................... 4 
1.2 BIOMATERIALS .............................................................................................................................. 6 
1.2.1 Natural Biomaterials from ECM ............................................................................................. 6 
1.2.2 Other Natural Biomaterials ..................................................................................................... 8 
1.3 HYALURONIC ACID AND ALGINATE HYDROGELS FOR SCI REPAIR ................................................. 9 
1.3.1 Hyaluronic Acid and Covalent Modification ........................................................................... 9 
1.3.2 Alginate and Ionic Crosslinking ............................................................................................ 14 
1.4 SCAFFOLD FABRICATION ............................................................................................................. 16 
1.4.1 Design of Scaffolds .............................................................................................................. 16 
1.4.2 Fabrication of Scaffolds ........................................................................................................ 22 
1.4.3 Dispensing-Based Rapid Prototyping Technique ................................................................... 24 
1.5 OBJECTIVES ................................................................................................................................. 26 
 VI 
1.6 ORGANIZATION OF THE DISSERTATION ........................................................................................ 26 
CHAPTER 2 Syntheses and FTIR Measurements of Composite Hydrogels ............................... 28 
2.1 INTRODUCTION ............................................................................................................................ 28 
2.2 MATERIALS AND METHODS ......................................................................................................... 28 
2.2.1 Sample Preparation for FTIR ................................................................................................ 29 
2.2.2 FTIR Measurement ............................................................................................................... 33 
2.3 RESULTS AND DISCUSSIONS ......................................................................................................... 33 
2.4 CONCLUSIONS ............................................................................................................................. 43 
CHAPTER 3 Biocompatibility of Alginate/Hyaluronic acid Hydrogels ..................................... 45 
3.1 INTRODUCTION ............................................................................................................................ 45 
3.2 MATERIALS AND METHODS ......................................................................................................... 45 
3.2.1 Schwann Cell Culture ........................................................................................................... 45 
3.2.2 Substrate Preparation ............................................................................................................ 46 
3.2.3 Cell Seeding and MTT Assay ............................................................................................... 47 
3.2.4 Statistical Analysis ............................................................................................................... 48 
3.3 RESULTS AND DISCUSSIONS ......................................................................................................... 49 
3.4 CONCLUSIONS ............................................................................................................................. 55 
CHAPTER 4 Fabrication and Mechanical Characterization of Alginate/Hyaluronic Acid 
Scaffolds ................................................................................................................................... 57 
4.1 INTRODUCTION ............................................................................................................................ 57 
4.2 MATERIALS AND METHODS ......................................................................................................... 58 
4.2.1 Preparation of Alginate/Hyaluronic Acid Mixture ................................................................. 58 
4.2.2 Viscosity Measurement ........................................................................................................ 59 
4.2.3 Fabrication of Multilayer Scaffolds ....................................................................................... 60 
4.2.4 Mechanical Test ................................................................................................................... 65 
 VII 
4.2.5 Statistical Analysis ............................................................................................................... 67 
4.3 RESULTS AND DISCUSSIONS ......................................................................................................... 67 
4.3.1 Flow Behavior ...................................................................................................................... 67 
4.3.2 Scaffold Fabrication ............................................................................................................. 69 
4.3.3 Mechanical Properties .......................................................................................................... 76 
4.4 CONCLUSIONS ............................................................................................................................. 79 
CHAPTER 5 General Discussion .............................................................................................. 81 
5.1 SUMMERY AND CONCLUSIONS ..................................................................................................... 81 
5.2 DISCUSSIONS ............................................................................................................................... 83 
5.3 RECOMMENDATIONS FOR FUTURE WORK .................................................................................... 91 
LIST OF REFERENCES .......................................................................................................... 93 
 
 VIII 
LIST OF TABLES 
 
Table                                                                                                                                           Page 
Table 1.1 Different Scaffold Fabrication Techniques for SCI Repair ......................................... 23 
Table 2.1 Conditions Used to Prepare Different Samples for Crosslinking of Hyaluronic Acid .. 30 
Table 2.2 Conditions Used to Prepare Different Samples for Crosslinking of Alginate .............. 31 
Table 2.3 Conditions Used to Prepare Different Samples for Crosslinking of Alginate/Hyaluronic 
Acid .......................................................................................................................................... 32 
Table 2.4 IR Peak Assignment for Different Chemical Bonds of Alginate/hyaluronic acid 
Crosslinking .............................................................................................................................. 34 
Table 4.1 Calculated and Experimental Flow Rate, and Strut Diameter Correspondent to 
Different Nozzle Deposition Velocities for 1.5% Alginate/0.75% Hyaluronic Acid ................... 62 
Table 4.2 Flow Behavior Parameters for Four Alginate/Hyaluronic Acid Mixtures ................... 68 
 
 
 IX 
 
LIST OF FIGURES 
Figure                                                                                                                                         Page 
Figure 1.1 Structure of spinal cord and distribution of dorsal and ventral roots ............................2 
Figure 1.2 Cross-sectional diagram of the spinal cord showing the distribution of the major 
ascending and descending pathways essential for neurological functions .....................................3 
Figure 1.3 Chemical structure of hyaluronic acid ....................................................................... 10 
Figure 1.4 Crosslinking of hyaluronic acid using EDC as the crosslinker .................................. 12 
Figure 1.5 Schematic diagram of the mechanism of amide formation mediated by carbodiimide 
in aqueous media....................................................................................................................... 13 
Figure 1.6 Schematic diagrams of the (A) mannuronate (M), guluronate (G) monomers of 
alginate sodium and (B) an example of the alginate polymer consisting of repeating GGMMG . 15 
Figure 1.7 Gel formation of alginate with divalent calcium cations to form ............................... 16 
Figure 1.8 Schematic of a dispensing-based rapid prototying system and an example of scaffolds 
produced by this system ............................................................................................................ 25 
Figure 2.1 FTIR spectra of plain hyaluronic acid, hyaluronic acid stirred with EDC, and 
hyaluronic acid_ADH mixtures stirred with EDC after dialysis and lyophilization .................... 35 
Figure 2.2 FTIR spectra of 1.5% alginate_MES_5.5_ADH crosslinked with CaCl2, EDC or both 
CaCl2 and EDC ......................................................................................................................... 37 
Figure 2.3 FTIR spectra of 1.5% alginate_0.375% hyaluronic acid_ADH_PH mixtures 
crosslinked with CaCl2, EDC or both CaCl2 and EDC under mixing or dispensing conditions ... 38 
Figure 2.4 Effect of CaCl2 concentration on the covalent crosslinking of 1.5% alginate_0.375% 
hyaluronic acid_ADH_PH......................................................................................................... 40 
Figure 2.5 Effect of EDC concentration on the covalent crosslinking of 1.5% alginate_0.375% 
hyaluronic acid_ADH_PH......................................................................................................... 41 
Figure 2.6 Effect of pH value on the covalent crosslinking of (a) hyaluronic acid, and (b) 
alginate/hyaluronic acid mixture ............................................................................................... 42 
 X 
 
Figure 3.1 Schwann cell morphology after 2 days’ culture on different 2D substrates ................ 50 
Figure 3.2 Morphology of Schwann cells after 2 days’ culture on different substrates ............... 51 
Figure 3.3 MTT result for the cell number of Schwann cells after 2 days’ culture on the double-
crosslinked alginate/hyaluronic acid hydrogel films .................................................................. 52 
Figure 3.4 MTT result of Schwann cells after 2 days’ culture on the ionically crosslinked and 
double-crosslinked alginate/hyaluronic acid hydrogels .............................................................. 53 
Figure 4.1 Wells/Brookfield DV-III+ Cone/Plate rheometer and  sample cup spindle ................ 59 
Figure 4.2 Adapted commercial fluid dispensing machine ......................................................... 61 
Figure 4.3 3D Bioplotter
TM
 system and its sample products ....................................................... 65 
Figure 4.4 The ElectroForce® 3100 test instrument ................................................................... 66 
Figure 4.5 Shear stress vs. shear rate curves of alginate/hyaluronic acid mixtures at different 
shear rates ................................................................................................................................. 68 
Figure 4.6 Viscosity vs. shear rate curves of alginate/hyaluronic acid mixtures ......................... 69 
Figure 4.7 Images of 1.5% alginate/0.75% hyaluronic acid scaffolds dispensed at different 
velocities and correspondent mass flow rates ............................................................................. 70 
Figure 4.8  Assessment of the effect of initial needle height on the strut diameter and linearity . 71 
Figure 4.9 Effect of CaCl2 concentration on strut diameter of 1.5% alginate/0.375% hyaluronic 
acid hydrogel scaffolds .............................................................................................................. 73 
Figure 4.10 Examples of the multilayer 1.5% alginate/0.375% hyaluronic acid scaffolds 
fabricated by the adapted fluid dispensing system ..................................................................... 74 
Figure 4.11 An example of the multilayer scaffolds fabricated by the 3D Bioplotter
TM
 system .. 75 
Figure 4.12 Stress-strain curves of cylindrical alginate/hyaluronic acid hydrogels measured at the 
strain rate of 0.0083/s ................................................................................................................ 77 
Figure 4.13 Average elastic moduli of ionically crosslinked hydrogels of 1.5% alginate with 0% , 
0.375%, 0.5% and 0.75% hyaluronic acid ................................................................................. 78 
 XI 
 
Figure 4.14 Average tangent moduli of four alginate/hyaluronic acid hydrogels at the strain of 
0.18 ........................................................................................................................................... 78 
 
 
 XII 
 
LIST OF ABBREVIATIONS 
2D Two dimensional 
3D Three dimensional 
ADH Adipic dihydrazide 
CAD Computer-aided design 
CNS Central nervous system 
DMEM Dulbecco's Modified Eagle Medium 
DRG Dorsal root ganglia 
EDC 1-Ethyl-3-(3-dimethylaminopropyl) carbodiimide 
EDTA Ethylenediaminetetraacetic acid 
FBS Fetal bovine serum 
FTIR Fourier transform infrared spectroscopy 
G Guluronate 
IKVAV Ile-Lys-Val-Ala-Val 
KBr Potassium bromide 
M Mannuronate 
MES 2-(N-morpholino) ethanesulfonic acid hydrate 
MTT 3-(4, 5-dimethylthiazol-2-yl)-2, 5-diphenyltetrazolium bromide 
PBS Phosphate buffer solution 
PLL Poly-L-lysine hydrobromide 
PNS Peripheral nervous system 
RGD Arg-Gly-Asp 
 XIII 
 
SCI Spinal cord injuries 
YIGSR Tyr-Ile-Gly-Ser-Arg 
 
 1 
 
CHAPTER 1 Introduction and Objectives 
Thousands of people suffer spinal cord injuries (SCI) due to motor vehicle accidents, 
falls, violence, and sports injuries, among other causes. About 12,000 new cases of spinal cord 
injury occur each year in the United States, with the estimated annual number of Americans 
living with SCI at approximately 259,000 [1]. Damage to the spinal cord has severe clinical 
consequences due to neuronal cell death at the site of injury, and the disruption of axonal 
pathways crossing through the site of injury. To date, functional training is the principal clinical 
therapy used to help rehabilitate individuals after SCI. Other clinical treatments, such as anti-
inflammatory drugs, help to prevent secondary injury and to reduce pain and swelling, but do not 
promote tissue repair. Therefore, therapeutic strategies to restore lost tissue and reestablish 
axonal connectivity after SCI are still urgently needed.  
 
1.1 Spinal Cord Injuries 
1.1.1 Organization of Spinal Cord 
 The nervous system consists of the central nervous system (CNS; brain and spinal cord) 
and the peripheral nervous system (PNS; nerves and ganglia outside the CNS). Spinal cord tissue 
is organized so that gray matter is in its centre, composed of neurons, neuropil (small axon 
terminals, dendrites, and the synaptic contacts they make with each other) and glial cells. The 
spinal cord white matter columns surround the gray matter, containing ascending and descending 
axons that travel long distances to establish contacts between different spinal levels, and with the 
brain. These white matter axonal pathways also contain glial cells, particularly the 
oligodendrocytes that provide a covering of insulating myelin to the long axons. Dorsal roots of 
the peripheral nerves relay sensory information to the posterior horn of the spinal cord gray 
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matter, while the ventral roots leaving the anterior horn carry the motor information to muscles 
and visceral organs as shown in Figure 1.1. 
  
Figure 1.1 Structure of spinal cord and distribution of dorsal and ventral roots [2]. Sensory 
neurons in the dorsal root ganglion (DRG) receive and relay the sensory information through 
the dorsal roots of the spinal nerve to the posterior horn of the spinal cord gray matter, and the 
ventral roots of the spinal nerve leaving the anterior horn carry the motor information to 
muscles and visceral organs. 
 
Different axon tracts in different locations of spinal cord white matter convey various 
types of information (Figure 1.2). For example, the fasciculus cuneatus and fasciculus gracilis 
carry ascending touch information, the anterolateral system carries ascending pain and 
temperature information, and the spinocerebellar tracts provide ascending sensory feedback 
about body movement. Meanwhile, the corticospinal tracts, the rubrospinal tract, and the 
vestibulospinal tracts carry descending information that controls muscle movement. The current 
emphasis of tissue engineering for SCI repair is to promote re-growth of these essential tracts 
after injury, which should in turn lead to dramatic restoration of sensory and motor function.  
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Figure 1.2 Cross-sectional diagram of the spinal cord showing the distribution of the major 
ascending and descending pathways essential for neurological functions [2]. 
 
1.1.2 Spinal Cord Injury  
Many factors impede the re-growth of ascending and descending axons that carry signals 
between the different levels of the spinal cord and the brain, and thereby prevent functional 
recovery after SCI. The failure of regenerative axonal growth is in large part attributable to a 
CNS environment that is inhibitory for axonal growth. Factors contributing to growth inhibition 
in the spinal cord include poor clearance of damaged tissue caused by slow Wallerian 
degeneration, scarring caused by astrocytes, the presence of myelin-associated axonal growth 
inhibitors produced by oligodendrocytes and lack of intrinsic regenerative capability [3-8]. The 
current focus of tissue engineering research is to develop strategies to overcome the unfavorable 
nature of the scarring, enhance intrinsic axonal regeneration ability, increase the number of 
damaged ascending and descending axons that regenerate, guide the regenerating axons back to 
their appropriate target regions, and encourage the remyelination of these regenerating axons [7, 
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9-12]. In the past few years, considerable progress has been made in the development of 
bioengineered tissue scaffolds for the promotion of spinal cord repair.  
 
1.1.3 Therapeutic Strategies for Spinal Cord Repair 
The goal of tissue engineering for SCI is to create functional tissue repair in a controlled 
environment that promotes and directs axonal re-growth and penetration into the host spinal 
cord. Signals such as diffusible factors, extracellular matrix (ECM) proteins, cell-cell interaction, 
and mechanical stress can be utilized to create a favorable environment for axonal outgrowth, as 
cells continually sense and respond to these signals [13]. Nerve guidance scaffolds can provide 
mechanical support for axonal re-growth and serve as a local delivery system for growth factors, 
and living cells by allowing cell attachment, migration, and differentiation [14]. Thus, 
bioengineered tissue constructs have shown potential for the repair of the injured spinal cord. 
Such strategies as electrical stimulation [15-17], incorporation of bioactive molecules and living 
cells [17-22], delayed transplantation of scaffolds [23-26] and overcoming the hostile 
environment [27-30] have been demonstrated to promote axonal regeneration after SCI.  
Schwann cells, the major glial cell type of the PNS, have been investigated for restoring 
injured spinal cord since 1981, when transplantation of purified Schwann cells was first carried 
out [31]. Schwann cells show particular promise as they can be harvested from patients for an 
autologous transplant. Not only do they provide remyelination of regrowing axons when 
transplanted into injured spinal cord [22], but the infiltration and remyelination by endogenous 
Schwann cells from the peripheral nerves into the spinal cord lesion site has been observed, 
suggesting that host Schwann cells might contribute to the recovery of injured spinal cord [25]. 
Transplantation of Schwann cells can reduce the size of spinal cysts as well as secrete various 
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trophic factors and cell adhesion molecules, leading to a more permissive environment for axonal 
growth and neural survival [32]. Trophic factors that Schwann cells produce include nerve 
growth factor, brain derived neurotrophic factor, ciliary neurotrophic factor, neurotrophin-3, 
conserved dopamine neurotrophic factor and fibroblast growth factor [33, 34]. In addition, they 
express axon guidance cell adhesion molecules on their surfaces, such as laminin. Schwann cell 
culture on/within the scaffolds is also extensively employed in preliminary studies to study such 
properties as biocompatibility and effects on cell behavior before the neural cell culture and in 
vivo transplantation. As a result, Schwann cells are used in this study to evaluate the 
biocompatibility and substrate-cell interaction of the biomaterial. 
Despite the beneficial outcome provided by Schwann cell transplantation, decreasing cell 
numbers after transplantation pose a problem and some studies show insufficient axonal 
regeneration of brainstem spinal axons using Schwann cells alone; axons moreover, do not leave 
the Schwann cell graft to reenter the distal host spinal cord. Thus, strategies combining scaffolds 
with bioactive molecules or other supportive cells are usually used [35, 36]. Both olfactory 
ensheathing cells and Schwann cells have been widely used to promote axonal re-growth and 
functional recovery for SCI, yet it is still under investigation which is more beneficial [37, 38]. 
Studies of regenerating adult rat spinal cord with moderate contusion lesions at the thoracic level 
demonstrate that Schwann cells lead to more hindlimb locomotor recovery than olfactory 
ensheathing cells despite their relatively low integration with astrocytes [39]. Whether this also 
holds for non-human primates or other injury models remains to be determined. The low 
integration and migration of transplanted Schwann cells with the astrocytes is considered to be 
related in part to the high level of heparan sulfate proteoglycans, which mediate astrocytosis by 
facilitating the activity of the fibroblast growth factor family of growth factors [40]. However, by 
 6 
 
forcing the transplanted Schwann cells to over-express the polysialylated neural cell adhesion 
molecule, their integration and migration in the spinal cord were improved, resulting in better 
axonal regeneration, remyelination and functional restoration [22, 41].  
 
1.2 Biomaterials 
Implantation of substrates such as cellular grafts can promote re-growth of axons after 
SCI. However, the growth of axons is highly random and does not extend past the graft site to re-
enter host tissue [42]. Artificial tissue scaffolds are designed to provide mechanical support for 
axonal re-growth and to potentially serve as a local delivery system for growth-promoting 
factors, growth-inhibitor neutralizing agents, or other therapeutic drugs, as well as a carrier for 
supportive cells that might facilitate repair. Biomaterials selected for construction of tissue 
scaffolds should meet the following criteria: biocompatibility with the host tissue to avoid 
adverse immune reactions; an adjustable rate of degradation; and degradation products that are 
non-toxic [9]. Specific to the needs of spinal cord repair, scaffold biomaterials with mechanical 
properties (specifically the elastic modulus) matched to that of the spinal cord at the lesion site 
has the ability to reduce astrocytic reaction and fibroblastic gliosis, and allow for cell adhesion 
and axonal re-growth.  
 
1.2.1 Natural Biomaterials from ECM 
Both natural and synthetic biomaterials have been modified to fabricate tissue scaffolds 
for SCI repair and are reviewed in detail in [43, 44]. Natural biomaterials used as scaffold 
construct materials for spinal cord repair include hyaluronic acid, alginate, collagen, agarose, 
chitosan, matrigel, fibrin, and fibronectin hydrogels. These hydrogels mimic the ECM of soft 
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tissue, being highly hydrated, soft and allowing for the exchange of nutrients and metabolic 
waste with surrounding tissues. On the other hand, the options for use of available synthetic 
biomaterials for SCI repair are quite limited due to the fact that the synthetic materials are mostly 
hard and therefore not suitable for the repair of soft tissues. Thus, hydrogels prepared from 
natural biomaterials are the focus of bioengineered scaffolds for SCI repair and discussed in 
detail in the following. 
Matrigel, fibrin, fibronectin, collagen and hyaluronic acid are components of native ECM 
and have been widely investigated for tissue engineering application due to their ability in 
regulating cell behavior. The ECM constituents provide anchorage and mechanical buffering, 
trigger intercellular communication and segregate different tissues [45].  
Matrigel is an ECM extracted from the Engelbreth Holm Swarm sarcoma and contains 
laminin, fibronectin and proteoglycans. It has ability to stimulate proliferation and adhesion of 
Schwann cells, bone marrow stromal cells and olfactory ensheathing cells as well as neurite 
outgrowth of DRG neurons [46]. However, its origin from mouse tumor cells limits its 
application in human spinal cord.  
Fibrin is a protein formed by enzymatic crosslinking of fibrinogen and thrombin upon 
mixing at physiological temperature and pH. It has been used as a delivery system for 
neurotrophic factors, chondroitinase ABC and different supportive cells, which result in 
increased axonal sprouting, decreased level of inhibitory molecules and significant behavioral 
recovery [47-51]. Unfortunately, the in vivo residence time of fibrin is not sufficient for SCI 
repair and needs to be prolonged.  
Fibronectin is a glycoprotein present outside cells and on the cell surface. It has 
neuroprotective effect on SCI and permits oriented axonal regeneration with infiltration of 
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macrophages, Schwann cells, oligodendrocytes and their precursors, and astrocytes. But the 
forms of fibronectin biomaterials are limited to the fibronectin mats or cables [52-54].  
Collagen can promote neural cell attachment and growth while on the other hand 
collagen is one component of the glial scar, which was suggested to impose a physical and 
chemical barrier for axonal regeneration after SCI [55-57]. In addition, though collagen is a 
major component of many tissue types in the body, native CNS tissue contains relatively little 
collagen. It is argued that the presence of biomaterial scaffolds consisted of un-naturally high 
concentration of collagen might impose undesirable side effects [58]. On the contrary, the native 
ECM of CNS contains high amounts of linear polysaccharides and glycosaminoglycans such as 
hyaluronic acid, chondroitin sulfate and heparin sulfate [59]. Chondroitin sulfate and heparin 
sulfate are also components of the glial scar and therefore are problematic to be used as natural 
biomaterials for the construct of scaffolds for SCI repair. Based on the discussion above about 
different natural biomaterials originated from ECM as well as the beneficial features provided by 
hyaluronic acid for spinal cord repair (discussed in section 1.3), hyaluronic acid was chosen as 
one natural biomaterial for the construct of 3D scaffolds for SCI repair. 
 
1.2.2 Other Natural Biomaterials  
Other natural biomaterials used for tissue engineering application include chitosan, 
agarose and alginate. Chitosan is a glycosaminoglycan carbohydrate polymer derived from 
chemical deacetylation of chitin, the major structural polysaccharide found in crustacean and 
insect exoskeleton. It has excellent ability for cell adhesion, survival and proliferation. 
Myelinated and unmyelinated axons as well as blood vessels were found after transplantation of 
extramedullary chitosan channel in a full transection SCI animal model [60]. On the other hand, 
 9 
 
there are studies indicating that chitosan can trigger inflammation with the severity dependent on 
the degree of deacetylation [61]. Implanted as scaffolds in brain, chitosan biomaterials are 
ingested by macrophages as part of a foreign body response [62]. This limits the application of 
chitosan scaffolds in SCI repair.  
Agarose is a linear polysaccharide derived from seaweed. It is an alternating copolymer 
of 1, 4-linked 3, 6-anhydro-α-L-galactose and 1, 3-linked β-D-galactose. Agarose is 
thermoresponsive, and can gel at temperatures ranging from 17-40 °C depending on the degree 
of hydroxyethyl substitution on its side chains. Agarose nerve guidance scaffolds with uniaxial 
linear channels prepared by a freeze-dry process or templating were shown to orient and provide 
guidance to local spinal cord axons after SCI [63-65]. But the non-degradability property of 
agarose scaffolds seems to be disadvantageous for SCI repair. Scaffolds with a matching in vivo 
biodegradation profile with new tissue formation are desirable for tissue regeneration. 
Alginate is preferable to these natural biomaterials in terms of its biorestorability, 
biocompatibility and facilitation of scaffold fabrication by instant gelation with multivalent 
cations under mild conditions. Detailed properties of alginate hydrogels and its potential as a 
biomaterial for the construct of scaffolds for SCI repair are discussed in section 1.3. 
 
1.3 Hyaluronic Acid and Alginate Hydrogels for SCI Repair 
1.3.1 Hyaluronic Acid and Covalent Modification 
Hyaluronic acid, widely found in almost all extracellular tissue spaces, is an extremely 
long, negatively charged, heavily hydrated glycosaminoglycan. It is comprised of repeating 
disaccharide units of β-1, 4-D-glucuronic acid and β-1, 3-N-acetyl-D-glucosamine, as shown in 
Figure 1.3. Its hydroxyl groups and carboxyl groups can be targeted for chemical modification. 
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Hyaluronic acid demonstrates excellent biological properties, being biocompatible, 
biodegradable and immunoneutral. Hyaluronic acid is widely investigated for its potential for 
construction of tissue scaffolds. It promotes regeneration of the traumatized peripheral nerve [66-
68], in part because of its involvement in such complex cell signaling events as migration, 
attachment, angiogenesis and neuronal sprouting [69]. In addition, it shows potential for SCI 
repair as it is shown to inhibit scar formation by inhibiting lymphocyte migration, proliferation, 
and chemotaxis; granulocyte phagocytosis and degranulation; and macrophage motility.  
 
The abundance of hyaluronic acid in brain and spinal cord also demonstrates its 
significance in CNS development, which inspired researchers to investigate the possibility of 
controlling neuronal progenitor cell differentiation through fabrication of hyaluronic acid 
hydrogels with tunable mechanical properties [70-72]. Several studies have been conducted to 
investigate the promise of crosslinked hyaluronic acid hydrogels on neurite outgrowth and 
recovery from SCI. Recent studies examining brain injury in rats show improved cell infiltration 
and angiogenesis in hyaluronic acid hydrogel scaffolds engineered to incorporate laminin 
peptides [73], or covalently crosslinked with poly-D-lysine, a widely used adhesive coating 
material in the preparation of neuron cultures [74]. Such polymer combinations may also have 
Figure 1.3 Chemical structure of hyaluronic acid consisting of repeating disaccharide 
units of β-1, 4-D-glucuronic acid and β-1, 3-N-acetyl-D-glucosamine. 
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promise for the treatment of SCI. But its short residence time in vivo and weak mechanical 
properties turn out to limit the application of hyaluronic acid in the construction of 3D scaffolds 
for spinal cord restoration.  
Numerous methods have been developed to chemically modify hyaluronic acid to control 
its mechanical properties and promote release of tethered bioactive agents, such as neutralizing 
antibody against Nogo receptor-66 to block the activity of myelin-associated neurite growth 
inhibitors in injured rat brain and spinal cord [75, 76]. The application of crosslinked thiolated 
hyaluronic acid-poly (ethylene glycol)-diacrylate scaffolds resulted in extensive neurite 
outgrowth in vitro, yet neither axonal regeneration nor behavioral recovery after spinal cord 
transection was observed [77]. Possible explanations for the lack of functional recovery include 
the incapacity for the crosslinked hyaluronic acid scaffolds to provide mechanical support for 
axonal growth beyond 8 days and the persistence of a strong inflammatory response. It is 
unlikely that hyaluronic acid scaffolds alone can lead to the behavioral restoration without 
additional strategies, for instance, the inclusion of living cells or growth factors. Still, cells do 
not readily adhere to hyaluronic acid suggesting that modifications to its surface properties may 
improve the efficacy of a hyaluronic acid scaffold.  
In vivo residence of hyaluronic acid can be enhanced by covalent chemical modification. 
The formation of amide bonds with adipic dihydrazide (ADH) mediated by 1-ethyl-3-(3-
dimethylaminopropyl) carbodiimide (EDC) has been demonstrated to enhance the mechanical 
strength and to control the in vivo biodegradation of crosslinked hyaluronic acid constructs [78]. 
A schematic diagram of chemical crosslinking of hyaluronic acid is shown in Figure 1.4.  
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Figure 1.4 Crosslinking of hyaluronic acid using EDC as the crosslinker [78]. Carboxyl groups 
of the hyaluronic acid can react with the amine groups of the ADH at an acid condition with the 
presence of EDC to give hyaluronic acid-ADH linked by the amide bonds. With the bifunctional 
ADH, the crosslinked hyaluronic acid-ADH-hyaluronic acid will be formed. 
 
The carboxyl groups of the hyaluronic acid will react with the amine groups of ADH to 
form the amide bonds under the mediation of EDC at an acid condition. Since the ADH is 
bifunctional, intermolecular and intramolecular crosslinking of hyaluronic acid through the 
amide bonds will take place, which overcomes the insufficient mechanical strength of hyaluronic 
acid scaffolds. In this reaction, EDC is transferred into urea, which is non-toxic to the native 
tissue. 
The comprehensive mechanism of the amide formation mediated by EDC in aqueous 
system is illustrated in Figure 1.5, which is quite different and complex from the case in the 
organic system. EDC can react with the ionized carboxyl group to form nucleophilic compound 
3 (O-acylisourea), which will then react with ionized carboxyl group and produce carboxylic 
anhydride 8 in the case of the cyclizable carboxyl group, which will form the corresponding 
amide 7 and urea derivative 2 when amine is present. For the non-cyclizable carboxyl group, 
compound 4 will react with a water molecule or a unionized amine to give carboxylate 6 or 
amide 7, respectively. The reaction with water will be prevailing. And if the carbodiimide is 
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added in excess, the carbodiimide would be able to react with compound 4 to form N-acylurea 5 
as a byproduct [79]. 
 
Figure 1.5 Schematic diagram of the mechanism of amide formation mediated by carbodiimide 
in aqueous media [79]. Carbodiimide 1 can react with an ionized carboxyl group to form 
compound 3 (O-acylisourea)and because of the reprotonation at the site of Schiff base, 
compound 3 can change into a carbocation 4, which will react with various bases in the aqueous 
system to yield different products. 
 
Previously, we found that 3D porous scaffolds cannot be produced using this chemistry, 
probably due to the non-instant crosslinking of the hyaluronic acid with the EDC in the aqueous 
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system. The extruded strands swell and collapse before extensive crosslinking takes place. As an 
alternative, it is possible that the inclusion of alginate, which can gel within seconds with 
divalent calcium cation (Ca
2+
), could provide the necessary mechanical support for the dispensed 
strands. Entrapped by the crosslinked alginate, hyaluronic acid will then be crosslinked and this 
may further enhance the mechanical strength of the fabricated scaffolds, and result in 3D porous 
scaffolds with a biodegradation rate suitable for use in SCI repair. There are not many 
investigations regarding use of the composite biomaterial of alginate/hyaluronic acid for the 
application of tissue engineering. Thus, this study may also provide insights into the potential of 
this composite biomaterial for the other tissue engineering applications.  
 
1.3.2 Alginate and Ionic Crosslinking 
Alginate is a water-soluble polysaccharide extracted from brown seaweed, consisting of a 
varying proportion of 1, 4-linked β-D-mannuronate (M) and 1, 4-linked α-L-guluronate (G) 
blocks (Figure 1.6), depending on the origin. Due to its biocompatibility and bioresorption 
properties, alginate has been widely used in tissue engineering to encapsulate and implant 
various growth factors or cell types into lesion sites to enhance the rate of tissue regeneration 
[80, 81]. In addition, several strategies have been proposed to control the degradation rate of 
alginate hydrogels, such as incorporating poly (lactide-co-glycolide) microspheres loaded with 
alginate lyase [82]. Non-structured alginate-based substrates transplanted into the mammalian 
CNS cause no allergic or inflammatory reactions but promote only limited axonal regeneration 
[83]. Freeze-dried alginate sponge can guide axonal re-growth in transected rat spinal cord, with 
the formation of functional synapses identified by intracellular electrophysiological recording 
[84]. Furthermore, alginate-based highly anisotropic capillary hydrogels, when assessed in both 
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axonal outgrowth assays in vitro and adult rat spinal cord lesions in vivo, elicit highly oriented 
linear axonal re-growth and appropriate target neuron reinnervation [85]. 
 
Application of alginate in the fabrication of 3D scaffolds using the solid freeform 
fabrication technique has been demonstrated, either serving as the scaffold biomaterial itself or 
as supporting additive for other biomaterials. Its instant gelation with divalent cations enables the 
inclusion of living cells during the dispensing process (Figure 1.7), eliminating the potential 
toxicity of other crosslinking reactants while allowing for the fabrication of the 3D constructs. 
However, there is no further study using alginate scaffolds with interconnected pore networks for 
either in vitro or in vivo test for SCI repair. Use of calcium crosslinked alginate as a matrix has 
been shown to permit the viability and growth of Schwann cells, and the neurite outgrowth of 
chick embryo DRG neurons was promoted by 170% when Schwann cells were suspended in the 
gel [86]. However, alginate lacks the ability to trigger the cellular and molecular signaling within 
the mammalian system, making the composite biomaterials of alginate and hyaluronic acid 
promising for construction of bioengineered scaffolds for SCI repair. 
Figure 1.6 Schematic diagrams of the (A) mannuronate (M), guluronate (G) monomers of 
alginate sodium and (B) an example of the alginate polymer consisting of repeating 
GGMMG. 
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Figure 1.7 Gel formation of alginate with divalent calcium cations to form “egg box” structure 
[86]. Carboxyl groups in the guluronic acid monomers of the alginate bind to the divalent ions 
to form the “egg box” structure, resulting in the alginate hydrogels. 
 
1.4 Scaffold Fabrication 
1.4.1 Design of Scaffolds 
Several requirements should be met when designing scaffolds for SCI repair, including 
mechanical properties similar to native spinal cord, favorable surface chemistry, sufficient pore 
size, porosity, pore interconnectivity and surface area for cell loading and cell-surface interaction 
as well as axonal re-growth and nutrient transport, and a biodegradation profile that produces 
adequate residence time [65, 87, 88]. However, because the use of artificial scaffolds for the 
repair of SCI is in its infancy, what constitutes an optimal scaffold remains to be defined. 
Parameters such as morphology, architecture, mechanical properties, surface properties, 
biodegradation rate, composition of biological components, and the variations of these factors 
with time have a substantial effect on the outcome [89, 90]. Systematic consideration of all of 
these factors will maximize the outcome for a particular application. 
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1.4.1.1 Surface Chemistry 
Surface chemistry of the biomaterials including charges, functional chemical groups and 
ECM proteins/peptides needs to be taken into account as it influences the interaction of the 
scaffold with macromolecules and cells. Particular cell types adhere to polymers with different 
surface charges. For example, the number of mesenchymal stem cells cultured on a positively 
charged hydrogel is elevated compared to hydrogels with a negative or no charge. This is 
attributed to absorption of serum macromolecules onto the positively quaternary ammonium 
groups [23, 91].  
In addition to the surface charge of biomaterials, chemical functional groups present on 
the surface of biomaterial also affect cell behavior through the interaction of receptors on cell 
membranes with specific ECM proteins absorbed by different chemical groups [92, 93]. Recent 
studies on the response of neural stem cells to materials with different chemical groups in a 
serum-free culture system indicate the chemical groups themselves can impose effects on cell 
behavior without the involvement of ECM proteins [94]. Detailed mechanisms of scaffold 
surface chemistry with respect to cell responses are not well understood.  
Presence of ECM proteins/peptides on the biomaterial scaffolds also influence on cellular 
activities such as cell migration, axonal guidance, synaptogenesis, cell survival, differentiation, 
and myelination [95]. Incorporation of ECM proteins or peptides derived from them, either by 
coating, covalent crosslinking, or blending, may enhance cell adhesion, differentiation, migration 
and axonal outgrowth [96-100]. Collagen, fibronectin, and laminin are the most widely 
investigated ECM proteins for biomodification of scaffolds to achieve better axonal regeneration 
[99, 101-103]. Limitations of modification with whole ECM proteins include batch variation and 
the risk of disease transmission [104]. Thus, synthetically prepared amino acid sequences from 
the domains of ECM proteins responsible for cell-substrate interactions are used as alternatives. 
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Arg-Gly-Asp (RGD), Tyr-Ile-Gly-Ser-Arg (YIGSR), and Ile-Lys-Val-Ala-Val (IKVAV) are the 
three most commonly used cell adhesion peptides in tissue engineering to promote the 
biocompatibility and interaction of scaffolds with cells [97, 98]. However, which 
functionalization technique and protein/peptide species and concentration are most efficient for 
each different scaffold application is still unknown.  
 
1.4.1.2 Mechanical Properties and Biodegradation Rate 
Mechanical properties of the scaffolds need to be taken into consideration when 
designing scaffolds for SCI repair. The elastic modulus, one key parameter for the mechanical 
properties of scaffolds, has a great influence on the cell response, depending on the cell type and 
the range of modulus presented. Soft substrates promote axonal growth but suppress the growth 
of astrocytes [105]. Besides, proliferation of stem cells can be modulated through the control of 
the mechanical properties of the scaffolds. For example, hyaluronic acid hydrogels with 
mechanical properties comparable to those of neonatal brain are found to direct the 
differentiation of neural progenitor cells into neurons. On the contrary, neural progenitor cells 
within stiffer hydrogels, with mechanical properties comparable to those of adult brain, 
differentiate into mostly astrocytes [72]. In general, scaffolds with material elastic modulus 
matching that of the native growth environment are preferable for cell growth, differentiation and 
migration across the tissue-implant boundary [106]. The values of the elastic modulus of native 
spinal cord tissue are reported to be within the range of ~3 KPa to 300 KPa [107, 108]. Due to 
the effects of mechanical properties of scaffolds on cell behavior, it is important to tune the 
mechanical properties of scaffolds for a particular application.  
In addition to the suitable initial mechanical properties, the mechanical properties of 
scaffolds are also supposed to match the growth of new tissue to support cell proliferation and 
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neurite extension. Thus, scaffolds with biodegradation profile matching the new tissue formation 
are desirable. Basically, the two main degradation mechanisms of scaffolds in vivo include 
uniform bulk degradation due to hydrolysis and proteolytic degradation of natural materials by 
protease enzymes in the ECM or cells [109].  
Several strategies can be applied to control the mechanical properties and biodegradation 
of scaffolds. Firstly, chemical/enzymatic and physical crosslinking of the natural biomaterials 
offer an option to control the mechanical properties and degradation profile of the hydrogel 
scaffolds. Other methods include varying material composition and delivery of particular 
protease enzymes for the biomaterials [82]. In addition, mechanical properties and 
biodegradation rate of the scaffolds are correlated with the internal microstructure of scaffolds 
such as pore size, porosity, and interconnectivity. Fabrication techniques of rapid prototyping are 
capable to produce controllable and reproducible microstructure of the scaffolds, and therefore 
provide effective control over the mechanical properties and biodegradation rate of scaffolds. 
However, with the complexity of the in vivo environment, how to monitor and control over the 
properties of scaffolds in vivo is an issue that needs to be further addressed.  
 
1.4.1.3 Macro-Architecture and Micro-Architecture  
To date, macro-scale architectures investigated for SCI repair include hydrogels, sponges, 
single- and multi-channeled guidance tubes, and nanofiber scaffolds. Among these, multi-
channeled scaffolds have drawn much attention among researchers as the hollow cylindrical 
channels can guide regenerating axons while the polymer matrix provides local, sustained release 
of therapeutic agents [44]. Compared to a single lumen tube, they provide more surface area, 
allowing for more cell attachment and local release of incorporated growth factors. In the PNS, 
multi-channeled tissue repair scaffolds resembling the structure of multiple basal lamina tubes 
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increased the accuracy of motor axonal regeneration in a 1-cm gap in a rat sciatic nerve model 
compared to single channel conduits [110]. In SCI repair, longitudinal tubes in the scaffolds can 
be fabricated through templating or adapted freeze-drying techniques. Introduction of uniaxial 
channels supported linear, organized axonal re-growth and blood vessel infiltration than 
scaffolds with random porous structure [63, 111]. However, axon migration was found to be 
independent of the conduit diameters. 
 Anatomically inspired open-path designs for SCI facilitate axonal regeneration through 
the lesion site and limit secondary injury progression. In comparison, implants of cylinder, tube, 
and single-channeled scaffolds result in a doubling of defect length due to secondary damage, 
and lead to large scar and cyst formation with no neural tissue re-growth [112]. These indicate 
that the macrostructure of the scaffolds itself is enough to affect the axonal regeneration after 
SCI.  
Implants with anatomical guidance channels positioned for major ascending and 
descending axon tracts as well as branch structure of the guidance scaffolds may be beneficial 
for the regeneration of traumatic spinal cord, particularly in combination with therapeutic 
strategies involving living cells and bioactive molecules [113]. This necessitates the development 
of advanced fabrication techniques capable to produce sophisticated macro-structure of the 
scaffolds. Conventional fabrication techniques are unable to do so.  
Microstructure of the implanted scaffolds, particularly the porosity, pore 
interconnectivity, pore size, and orientation of pores, is also important when designing scaffolds 
for SCI repair due to its impact on mechanical properties, surface to volume ratios, and cell 
behavior. High porosity and interconnectivity of the pores are essential in ensuring spatially 
uniform cell distribution, cell survival, proliferation and migration in vitro [88]. These features of 
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scaffolds can extensively affect on the diffusion of physiological nutrients and gases to the 
removal of metabolic waste and by-products from cells that have penetrated the scaffold. In 
general, high porosity and pore interconnectivity are preferable. However, high porosity of 
scaffolds compromises the mechanical strength and thus the proper porosity of scaffolds should 
be made with considerate care.  
Pore size of the scaffolds should not be too small as pore occlusion by cells will inhibit 
cellular penetration and matrix elaboration within the scaffolds [88]. Meanwhile, it should be 
small enough to physically align and restrict the direction of axonal growth [114-116]. It is 
reported that axonal ingrowth into capillary alginate hydrogels was promoted with increasing 
capillary diameter from 18 µm to 55 µm. In another study, micropatterned grooves with widths 
of about 30 µm were found to be the most effective at promoting oriented neurite growth [117].  
Micropatterning, microgrooves, photolithography, soft lithography, self-assembling and 
electrospinning are usually used to produce micro- and nano-scale topography, which best mimic 
the native ECM and thus provide a suitable environment for cell adhesion, migration, 
proliferation and differentiation. Electrospinning has drawn particular attention due to its 
capacity to fabricate scaffolds with linear fibers within nano- to micro-scale range. Electrospun 
nanofibers with linear orientation result in the highly aligned neurite extension of DRG neurons 
parallel to the fibers [118, 119]. In addition to the guidance of neurite outgrowth, gene 
expression of β-Tubulin in Schwann cells is upregulated; proliferation and differentiation of 
mutlipotent cells can be affected [120-122]. Unfortunately, as toxic chemical solvents or high 
temperatures are required to dissolve most synthetic polymers before electrospinning, the 
incorporation of cells and/or bioactive molecules when fabricating scaffolds using this technique 
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is an issue that requires further investigation. And electrospinning of scaffolds consisted of 
natural biomaterials have not been achieved so far and the shape of scaffolds is limited.  
With the emergence of computer-aided design (CAD), scaffolds with controllable, 
reproducible and bio-mimetic micro-architecture can be fabricated with the rapid prototyping 
techniques, facilitating the application of different therapeutic strategies for various ascending 
and descending tracts [44]. Newer technologies give researchers greater capacity to control 
macro-structure, micro-structure, and biological properties during tissue scaffolds design and 
production, and this is important to support continued progress. The following section focuses on 
selected currently available fabrication techniques potentially applicable to spinal cord repair, 
with emphasis on rapid prototyping techniques.  
 
1.4.2 Fabrication of Scaffolds 
Enhancing the biological properties of scaffolds during the fabrication process is a 
primary goal of tissue engineering. Fabricating artificial scaffolds that are subsequently seeded 
with living cells in bioreactors and one-step fabrication of scaffolds using a mixed solution of 
biomaterial and living cells are both methods that belong to the biofabrication domain. Adding 
cells to scaffolds after they are fabricated imposes limits on the ability to control cellular 
distribution. Advantages of incorporating cells into the production process include the ability to 
produce an even spatial distribution of the living cells [123], or even to construct defined cellular 
arrays. Sustaining the viability of living cells during the fabrication process is essential, and 
emphasizes the importance of sterile and gentle fabrication procedures. While several techniques 
have been widely used to fabricate scaffolds with required surface morphology and internal 
architectures for SCI repair, techniques allowing the inclusion of living cells and bioactive 
 23 
 
molecules during the process are quite scarce. Different techniques used for scaffold fabrication 
and their merits and demerits are summarized in Table 1.1. 
 
Table 1.1 Different Scaffold Fabrication Techniques for SCI Repair 
Fabrication 
Methods 
Merits Demerits Reference 
Freeze drying 
No toxic chemicals needed 
Highly porous structures 
High pore  interconnectivity 
Control of porosity 
Random distribution of pores 
Incapable of fabricating intricate 
microstructure 
Limit to small pore sizes 
[64] 
Gas foaming 
Free of organic solvents and high    
temperature  
Controllable porosity and pore size 
High pressure involved 
Compact architecture for cells 
Lack of interconnectivity 
[124] 
Salt leaching/ 
Phase separation 
Allows incorporation of bioactive  
agents 
Residual solvents  [125] 
Mold casting 
Simple, cheap 
Requires no chemical agents 
Incapable of fabricating  
intricate microstructure  
[60] 
Electrospinning 
Produces long and continuous fibers 
Control over fiber orientation 
Versatile for many polymers 
Use of high-voltage apparatus 
Difficult to control fiber assembly 
Limited to viscous polymer solutions 
[99] 
Heat compression Free of organic solvents High temperature [126] 
 
Scaffold fabrication techniques can be divided into three groups: conventional methods, 
textile technologies and solid freeform fabrication. Conventional fabrication techniques are 
described in detail by Sachlos and Czernuszka [127], and include such methods as solvent-
casting, particulate-leaching, gas foaming, phase separation, melt molding, solution casting, and 
freeze-drying. These methods involve the use of toxic organic solvents and porogens, and lack 
the ability to precisely control the pore size, pore geometry, and spatial distribution of pores 
within the scaffolds. As these parameters play important roles in the material properties and 
functionality of the scaffolds, the utility of such conventional techniques is limited. Furthermore, 
whether the amorphous, irregular microstructure of conventionally fabricated scaffolds hinders 
longitudinal axonal regeneration remains to be determined.  
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1.4.3 Dispensing-Based Rapid Prototyping Technique 
Rapid prototyping, also known as solid freeform fabrication, has recently attracted 
increasing attention. Rapid prototyping can be used to fabricate scaffolds with controllable and 
reproducible microstructure, thanks to computer-aided fabrication processes that provide control 
over the physical properties (pore size, porosity, interconnectivity, and mechanical strength) of a 
scaffold as required for a particular application. Rapid prototyping using natural biopolymers is 
conducive to the simultaneous inclusion of cells and biomolecules. It is reported that rapid 
prototyped scaffolds provide better cell seeding in the scaffold interior, lower oxygen gradients, 
and better cell aggregation compared to conventional fabrication techniques, and can more 
successfully promote tissue regeneration [89, 128].  
Dispensing processes are most commonly used in rapid prototyping techniques and are 
termed as the dispensing-based rapid prototyping systems (Figure 1.8). Biomaterials are 
deposited in a predefined dispensing path to form the 3D scaffolds. These dispensing-based rapid 
prototyping systems, such as the 3D Bioplotter, are capable to fabricate hydrogel scaffolds and 
integrate supporting cells and bioactive molecules during the fabrication process without the 
involvement of toxic chemicals or high temperatures. However, few studies are carried out on 
the fabrication and in vivo characterization of rapid prototyped scaffolds for SCI repair. One 
work worth mentioning describes the fabrication of a new bi-phasic tubular scaffold by 3D 
bioplotting for SCI regeneration [129]. The favorable outcome of the preliminary in vivo test in a 
hemisection SCI model demonstrates the potential of the dispensing-based rapid prototyping 
technique to fabricate scaffolds with controllable microstructure, mechanical strength and 
biological patterns for enhanced promotion of axonal regeneration.  
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Despite of the advantages offered by this fabrication technique, it has so far proven 
difficult to precisely control the architecture of the scaffolds by varying such parameters as fluid 
behavior of the dispensing material, flow rate, dispensing speed, and dispensing nozzle shape, 
diameter and length. Different models have been developed to evaluate the flow rate with regard 
to the Newtonian or non-Newtonian fluid behaviors of different dispensing approaches [130-
133]. Modeling of scaffold porosity, pore size, and mechanical cell damage has also been carried 
out to offer an alternative to trial and error processes [134]. These models will greatly facilitate 
scaffold biofabrication, making it possible to optimize the geometry and process parameters, 
minimize cell damage during the biofabrication process, and maximize both mechanical and 
biological properties. Shortcomings of dispensing-based rapid prototyping fabrication include 
challenges regarding sterilization, cell damage that may occur during the fabrication process, and 
the inability to fabricate scaffolds from biomaterials that require a lengthy cross-linking process. 
 
Figure 1.8 (a) Schematic of a dispensing-based rapid prototyping system composed of two 
dispensers mounted on a three-axis positioning system, a stage to support the scaffolds 
fabricated, a personal computer and three controllers interfaced with the personal computer for 
the control of position, dispenser and temperature; and (b) top view of a multilayer orthogonal 
scaffold fabricated using the dispensing-based rapid prototyping method [133]. 
 
 
(b) (a) 
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1.5 Objectives 
In this research, crosslinked alginate/hyaluronic acid 3D scaffolds will be fabricated and 
characterized in terms of physical, biological and mechanical properties. The central hypothesis 
is that 3D scaffolds can be fabricated from crosslinked alginate/hyaluronic acid hydrogels and 
the composite hydrogels are permissive for Schwann cell viability and growth. If this hypothesis 
is supported, the alginate/hyaluronic acid composite material could be used in the future as the 
biomaterial to construct 3D scaffolds for SCI repair. To prove this, the following specific 
research objectives are to be achieved in this research: 
(1) To synthesize and chemically characterize double-crosslinked alginate/hyaluronic acid 
composite biomaterial;  
(2) To examine the biocompatibility of the crosslinked alginate/hyaluronic acid hydrogels 
for Schwann cell viability and growth; 
(3) To design and fabricate 3D porous scaffolds with well-controlled microstructure by 
dispensing-based rapid prototyping techniques; 
(4) To study the effect of concentration of hyaluronic acid on the mechanical properties of 
the ionically-crosslinked composite hydrogels. 
Overall, the present study will shed light on the application of alginate/hyaluronic acid 
hydrogel as a scaffold material that could serve as a platform for SCI repair. 
 
1.6 Organization of the Dissertation 
This dissertation is composed of five chapters in total, and each experimental chapter is 
divided into four main parts: introduction, materials and methods, results and discussions, and 
conclusions. 
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Chapter 1 presents a brief introduction and literature review on the bioengineered 
scaffolds for spinal cord repair. Specifically, it presents the recent development of bioengineered 
scaffolds for SCI repair, from the points of view of SCI, current therapeutic strategies, scaffold 
materials, and fabrication techniques.  
Chapter 2 presents the synthesis of double-crosslinked alginate/hyaluronic acid composite 
hydrogels and their characterization by means of Fourier transform infrared spectroscopy 
(FTIR). Covalent crosslinking of the composite material was applied and the chemistry was 
confirmed using FTIR spectroscopy. 
Chapter 3 discusses the biocompatibility of alginate/hyaluronic acid hydrogels for 
Schwann cell viability and growth. Schwann cell cultures were established on double-crosslinked 
alginate/hyaluronic acid hydrogels with different concentrations of alginate and hyaluronic acid 
to test the biocompatibility of the substrates. Also, the effect of concentration of hyaluronic acid 
incorporated and double crosslinking of alginate/hyaluronic acid biomaterial on Schwann cell 
number in comparison with just ionic crosslinking was studied to find proper substrates for the 
Schwann cell culture. 
Chapter 4 focuses on the fabrication of 3D porous scaffolds by the dispensing-based rapid 
prototyping technique. The effects of operating parameters, concentration of crosslinker solution 
and amount of hyaluronic acid incorporated on the formation of multilayer scaffolds were 
investigated. The mechanical properties of cylindrical ionically-crosslinked alginate/hyaluronic 
acid scaffolds were also studied by uniaxial compression test.  
Chapter 5 presents the main conclusions and discussion of this research, followed by 
comments for future work.  
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CHAPTER 2 Syntheses and FTIR Measurements of Composite Hydrogels 
 2.1 Introduction 
Hyaluronic acid has a great potential for constructing tissue scaffolds due to its 
excellent biological properties to trigger cellular and molecular signaling within the mammalian 
system. Unfortunately, hyaluronic acid has weak mechanical properties and cannot be used alone 
to fabricate 3D porous structures with the dispensing-based rapid prototyping system. In contrast, 
instant gel formation of alginate with calcium chloride (CaCl2) results in hydrogels with 
mechanical strength that can be handled and tailored to match the application of SCI repair. 
Thus, composite biomaterial of alginate and hyaluronic acid will facilitate the fabrication of 3D 
scaffolds using the dispensing-based rapid prototyping system meanwhile maintaining the 
biological properties of hyaluronic acid. Additionally, covalent crosslinking of 
alginate/hyaluronic acid with ADH mediated by EDC might prolong the in vivo residence time 
and enhance the mechanical properties of alginate scaffolds. FTIR spectra were used to confirm 
the amide formation of alginate/hyaluronic acid composite material in the presence of CaCl2 and 
EDC.  
 
2.2 Materials and Methods 
Low viscosity sodium alginate, molecular weight range 12,000~80,000 Da, mannuronic 
acid 61% and guluronic acid 39% was purchased from Sigma Aldrich Canada. Calcium chloride 
CaCl2 (Sigma, St. Louis, MO) was used as the crosslinker for sodium alginate. Hyaluronic acid 
sodium salt (MW 26-27 MDa) was bought from Shandong Freda Biopharm Co., Ltd. (Freda, 
Jinan, Shandong, China). ADH, 2-(N-morpholino) ethanesulfonic acid hydrate (MES buffer) 
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with useful pH range of 5.5-6.7, and EDC were all purchased from Sigma Aldrich Canada. 
Dialysis tubes having a 3500 Dalton molecular weight cut offs were used to dialyze the excess 
reagents. Potassium bromide (KBr) of the FTIR grade, ≥ 99% trace metals basis (Sigma Aldrich, 
Canada) was used for the FTIR spectrometers. 
 
2.2.1 Sample Preparation for FTIR 
2.2.1.1 Covalent Crosslinking of Hyaluronic Acid 
Three samples were used to examine the covalent modification of hyaluronic acid with 
ADH by EDC at an acid condition. They were hyaluronic acid reacted with EDC alone 
(HA_4_EDC_stir), hyaluronic acid reacted with ADH and EDC (HA_ADH_4_EDC_stir) and 
unreacted hyaluronic acid (HA), which served as the negative control. In detail, 0.75% (wt %) of 
hyaluronic acid was prepared by dissolving hyaluronic acid powder in double distilled water and 
stirred overnight. The pH value of the hyaluronic acid solution was adjusted by adding drop by 
drop of 10 mM HCl until it reached a value of 4. This pH value supports good covalent 
modification as discussed in Chapter 1. For sample HA_ADH_4_EDC_stir, both hyaluronic acid 
and ADH (w/w, 1:5) were dissolved in double distilled water and the pH value of mixture was 
also adjusted to 4 by HCl (HA_ADH_4). One mL of the mixtures from each experimental 
sample was then reacted with 1 mL of 50 mM EDC solution by stirring for hours. The hydrogels 
were then transferred to two presoaked dialysis tubes and dialyzed for 2 days with three water 
changes. After dialysis, the hydrogels were then transferred into clean plastic tubes and dried 
overnight in a Speed Vac before the FTIR measurement.  
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Table 2.1 Conditions Used to Prepare Different Samples for Crosslinking of Hyaluronic Acid 
Sample 
Abbrebiation 
Hyaluronic Acid 
(wt %) 
ADH 
(wt %) 
PH 
Value 
EDC 
(mM) 
Stirring or 
Immersion 
Dialysis 
and Dried 
HA_4_EDC_stir 
0.75%, H20 _ 4 50 Stirring Yes 
HA_ADH_4_EDC_stir 
0.75%, H20 3.75% 4 50 Stirring Yes 
HA 
Power _ _ _ _ _ 
 
2.2.1.2 Covalent Crosslinking of Alginate 
As the alginate precipitates at pH values lower than 3.5, depending on the molecular 
weight [135], the pH value of the alginate solution cannot be adjusted through adding HCl as 
was done for hyaluronic acid. To control pH we used MES buffer with the effective pH range of 
5.5-6.7 as it doesn’t have the carboxyl groups present to disturb the chemistry of the covalent 
crosslinking. Thus, the alginate was dissolved in 50 mM MES buffer with a pH value of 5.5 to 
prepare 3% alginate solution (3% alginate_MES_5.5). A mixture of 0.5 mL H2O and 0.5 mL 3% 
alginate_MES_5.5 was then stirred with ADH (1.875%, wt %) to get the alginate_ADH mixtures 
(1.5% alginate_MES_5.5_ADH). One mL of 1.5% alginate_MES_5.5_ADH reacted with 1 mL 
of 30 mM CaCl2 solution was then used as the negative control (1.5% 
alginate_MES_5.5_ADH_30mM CaCl2_dispense), while the experimental samples include 1.5% 
alginate_MES_5.5_ADH immersed within 1 mL of 100 mM EDC solution for 24 hrs (1.5% 
alginate_MES_5.5_ADH_100mM EDC_dispense) and 1.5% alginate_MES_5.5_ADH gelated 
with 1 mL of 30 mM CaCl2 solution first before further immersion in 1 mL of 100 mM EDC for 
24 hrs (1.5% alginate_MES_5.5_ADH_30mM CaCl2(first)_100mM EDC_dispense). Through 
this, we can identify whether the alginate can be covalently modified with ADH by EDC and 
also if alginate can be further covalently crosslinked after ionic crosslinking. After chemical 
reaction, the hydrogels were dialyzed and dried as described in section 2.2.1.1.  
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Table 2.2 Conditions Used to Prepare Different Samples for Crosslinking of Alginate 
Sample 
Abbreviation 
Alginate 
(wt %) 
ADH 
(wt %) 
CaCl2 
(mM) 
EDC 
(mM) 
Stirring or 
Immersion 
Dialys
is and 
Dried 
1.5% Alginate_MES_5.5_ADH_30mM 
CaCl2_dispense 
1.5%, 
MES 
buffer 
1.875% 30 _ Immersion Yes 
1.5% Alginate_MES_5.5_ADH_100mM 
EDC_dispense 
1.5%, 
MES 
buffer 
1.875% _ 100 Immersion Yes 
1.5% Alginate_MES_5.5_ADH_30mM 
CaCl2(first)_100mM EDC_dispense 
1.5% 
MES 
buffer 
1.875% 30 100 Immersion Yes 
 
2.2.1.3 Ionic and Covalent Crosslinking of Alginate/Hyaluronic Acid 
For the preparation of alginate/hyaluronic acid mixtures for ionic and covalent 
crosslinking (double crosslinking), 1.5% alginate, 0.375% hyaluronic acid was used. To achieve 
this without the use of HCl for adjusting the pH value, 3% alginate_MES_5.5 and 0.75% 
hyaluronic acid_ADH_4 were mixed at 1:1 volume ratio. This mixture has a final pH value of 
approximately 5 and the solution is symbolized as alginate_hyaluronic acid_ADH_PH in this 
work. One mL of alginate_hyaluronic acid_ADH_PH solution reacted with 1 mL of 100 mM 
EDC by stirring was termed as alginate_HA_ADH_PH_100mM EDC_stir. To examine the 
effect of addition of ADH, sample of alginate_hyaluronic acid_PH without ADH reacted with 1 
mL of 100 mM EDC was also used (alginate_HA_PH_100mM EDC_stir). And the one 
immersed within 100 mM CaCl2, or 100 mM CaCl2 and 100 mM EDC are labeled respectively 
as alginate_HA_ADH_PH_100mM CaCl2_dispense and alginate_HA_ADH_PH_100mM 
CaCl2_100mM EDC_dispense. Dialyzed alginate_hyaluronic acid_ADH_PH was termed as 
alginate_HA_ADH_PH_dialysis, which theoretically gives only alginate/hyaluronic acid after 
dialysis as ADH should be removed from the mixture during the dialysis process.  
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Table 2.3 Conditions Used to Prepare Different Samples for  
Crosslinking of Alginate/Hyaluronic Acid 
Sample Abbreviation 
3% 
Alginate_MES_5.5 
: 
0.75% Hyaluronic 
acid_4 (V/V) 
ADH 
(wt %) 
CaCl2 
(mM) 
EDC 
(mM) 
Stirring or 
Immersion 
Dialysis 
and 
Dried 
Alginate_HA_PH_100mM
_EDC_stir 
1:1 _ _ 100 Stirring Yes 
Alginate_HA_ADH_PH_ 
100mM_EDC_stir 
1:1 1.875% _ 100 Stirring Yes 
Alginate_HA_ADH_PH_ 
100mM CaCl2_dispense 1:1 1.875% 100 _ Immersion Yes 
Alginate_HA_ADH_PH_ 
100mM CaCl2_100mM 
EDC_dispense 
1:1 1.875% 100 100 Immersion Yes 
Alginate_HA_ADH_PH_ 
dialysis 1:1 1.875% _ _ Stirring Yes 
 
The effect of concentrations of CaCl2 and EDC as well as the pH value of the 
alginate/hyaluronic acid hydrogel formation was then investigated. Alginate_hyaluronic 
acid_ADH_PH mixtures were reacted with 100 mM EDC with various concentrations of CaCl2 
(0 mM to 100 mM) and the final products were examined by the FTIR spectra. Also, crosslinker 
solutions of 50 mM CaCl2 with different concentrations of EDC (0 mM to 100 mM) were used to 
crosslink alginate_hyaluronic acid_ADH_PH mixtures.  
For the experiment aimed to evaluate the effect of pH value on the covalent crosslinking, 
two methods were used to prepare 1.5% alginate_0.375% hyaluronic acid_ADH mixtures. One is 
to prepare as the way described above: mixing 3% alginate_MES_5.5 and 0.75% hyaluronic 
acid_ADH_4 at 1:1 volume ratio. Mixture prepared by this method is symbolized as 
alginate_HA_ADH_PH. The second method is to prepare MES buffer at pH value of 4. And then 
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dissolve the alginate, hyaluronic acid and ADH powders in this buffer to obtain mixture of 
alginate_HA_MES_4_ADH. PH value of the final mixture prepared in the second way was 
around 5.5, which was higher than that of alginate_HA_ADH_PH. The two mixtures were then 
immersed within 100 mM EDC solutions for crosslinking. 
To further understand the effect of pH value on the covalent crosslinking, similar 
experiment was done on hyaluronic acid. Briefly, one method was to adjust pH of hyaluronic 
acid_ADH mixture to 4, while the other method was to adjust pH of the hyaluronic acid solution 
to 4 first before adding ADH powder. Then the two mixtures were crosslinked by immersing 
them in 200 mM EDC crosslinker solution. All the crosslinked hydrogels were further dialyzed 
for 2 days with three times water changes and lyophilized on the Speed Vac, after which FTIR 
measurements were carried out. 
 
2.2.2 FTIR Measurement 
Lyophilized 10 mg samples of each reaction product were mixed with 300 mg dry KBr 
and pressed into a pellet using a macro KBr die kit. The solid pellet was analyzed using FTIR 
instrument (Perkin-Elmer, PerkinElmer Life And Analytical Sciences, Inc., USA). 
 
2.3 Results and Discussions 
To facilitate the following discussion, peak assignment for different chemical bonds in the 
organic chemicals is summarized in Table 2.4. As shown in Table 2.4, plain hyaluronic acid has 
the characteristics for carboxylate anions, which are absorption bands at 1600 cm
-1 
and 1412 cm
-1 
assigned to the asymmetric and symmetric strectching vibrations of carboxylate anions. Though 
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there are amide bonds in the plain hyaluronic acid, peaks for amide bonds in plain hyaluronic 
acid are not evident due to the small quantity of amide bonds. 
 
Table 2.4 IR Peak Assignment for Different Chemical Bonds of  
Alginate/Hyaluronic Acid Crosslinking 
Chemicals Functional Group Molecular Motion Wavenumber(cm
-1
) 
 
Alginate/hyaluronic acid 
(pH=~4) 
 
Carboxylic acid 
-COOH 
C=O stretching dimer ~1710 
C=O stretching monomer ~1735 
O-H bend 1440-1400 
O-H stretch 2500-3300 
C-O-H in-plane bend ~1415 
C-O stretch 1320-1210 
Alkane 
-CH3 
C-H stretch 2950-2800 
CH3-bend ~1375 
Amide bond 
-CO-NH- 
Secondary amide 
N-H bend (amide II band) 1530±30 
N-H strecth (>= 2 bands) 3330-3060 
C=O stretch 1630-1695 
ADH 
Amine 
-NH2 
Primary amine 
N-H stretch 
3400-3500 
(two bands) 
N-H bend (scissoring) 1580-1650 
C-N stretch 1000-1250 
Amide bond 
CO-NH- 
Secondary amide 
N-H bend (amide II band) 1530±30 
N-H strecth (>= 2 bands) 3330-3060 
C=O stretch 1630-1695 
Alkane 
-CH2 
CH2 bend (scissing) ~1458 
Crosslinked 
alginate/hyaluronic acid 
hydrogel 
Amide bond 
CO-NH- 
Secondary amide 
N-H bend (amide II band) 1530±30 
N-H strecth (>= 2 bands) 3330-3060 
C=O stretch 1630-1695 
Ester bond 
-COO 
C=O stretch 1750-1735 
C-C(O)-C stretch 1160-1210 
Carboxylate 
-COO- 
C=O stretch ~1620, ~ 1429 
 
      Crosslinking of hyaluronic acid with EDC leads to crosslinked hydrogels with enhanced 
mechanical strength. Spectrum of the resulted hydrogel shows the peaks at the wavenumber of 
1708 cm
-1
 and 1114 cm
-1
, which are assigned to the C=O stretch and C-C(O)-C stretch of ester 
bond, respectively. Also, there are characteristic peaks for amide bonds (1660 cm
-1
, 1550 cm
-1 
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and 1423 cm
-1
). This is propably due to undesired side reaction of the O-acylisourea to rearrange 
into the stable N-acylurea. As indicated in Figure 1.5, there is formation of N-acylurea when the 
carbodiimide is in excess. And since the N-acylurea is of high molecular weight, it cannot be 
gotten rid of during the dialysis process. However, as observed in Figure 2.1, there is a peak at 
the wavenumber of 1600 cm
-1
, which indicates that there are unreacted carboxylate groups with 
only EDC added. 
 
 
Figure 2.1 FTIR spectra of plain hyaluronic acid, hyaluronic acid stirred with EDC, and 
hyaluronic acid_ADH mixtures stirred with EDC after dialysis and lyophilization. Reaction 
of EDC with hyaluronic acid at pH of 4 led to the new characteristic peaks of ester bonds at 
1708 cm
-1
(purple dash line), and amide bonds at 1660 cm
-1
(red dash line) and 1550 cm
-1 
(blue dash line), with the remaining peak of carboxyl groups at 1600 cm
-1
(black dash line). 
Further addition of ADH into the hyaluronic acid, reacted with the presence of EDC, 
resulted in more amide bonds (red and blue dash line), but fewer ester bonds (purple dash 
line). And the amide formation was complete with no wave absorption at1600 cm
-1 
, 
indicating that all the carboxyl groups were transformed into ester bonds and particularly 
the amide bonds. 
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Crosslinking of hyaluronic acid_ADH_4 leads to the decrease of the peaks at 1708 cm
-1
, 
1114 cm
-1
, and 1405 cm
-1
, and increases the peaks at 1660 cm
-1 
(C=O stretch of secondary 
amide), 1550 cm
-1 
(N-H bend of amide) and 1423 cm
-1 
(C-N stretch of amide). This indicates the 
formation of more amide bonds when the ADH is added, which is consistant with the mechanism 
of EDC mediated crosslinking of carboxyl groups with amine groups. Morphologically, reaction 
of ADH with hyaluronic acid under the function of EDC resulted in crosslinked hydrogels, with 
better mechanical strength compared to the one without ADH added. This is attributed to the 
amine bonds and bifunctional property of ADH, leading to more covalent crosslinking.  
Crosslinking of 1.5% alginate with ADH by EDC also leads to the formation of amide 
bonds as demonstrated in Figure 2.2. MES buffer at pH of 5.5 is used as alginate precipitates at 
low pH values, making the adjustment of the pH of alginate solution problematic. As noticed, 
there is still existence of carboxylate anions, which is consistent with the morphology change. 
The resulted hydrogel is weak at mechanical strength, making it difficult to handle. When 
compared to the ADH-crosslinked hyaluronic acid, with the same reaction conditions, it seems 
that alginate was not completely covalently crosslinked. This is probably due to the insufficient 
amount of ADH or EDC added. And it was found that the coupling efficiency of amine acid to 
heparin and heparan sulfate is less efficient than that to other glycosoaminoglycan such as 
hyaluronic acid. It is proposed that the α‐L, 1‐4 glycosidic bonds between the uronic acid and 
glucosamine residues of the heparin and heparan sulfate is the main reason [136]. Similarly, it is 
likely that the structural difference of alginate and hyaluronic acid would lead to the difference in 
crosslinking extent between alginate and hyaluronic acid with ADH by EDC. Another possibility 
is that the pH value of 5.5 is not optimal for alginate crosslinking, or there is a part of carboxyl 
groups in alginate that do not crosslink with ADH by EDC.  
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It is also found that alginate after ionic crosslinking with CaCl2 can be further crosslinked 
by ADH to form the amides. This can be explained by the fact that carboxyl groups in the 
mannuronate blocks, which don’t bind to the CaCl2, can still react with ADH to form the amide 
bonds. But it remains to be determined whether the carboxyl groups in the guluronate blocks 
could form amide bonds with ADH. 
 
Covalent crosslinking of 1.5% alginate/0.375% hyaluronic acid mixture with ADH by 
EDC was demonstrated in Figure 2.3. Dialyzed mixture of alginate_hyaluronic acid_ADH_PH 
had the characteristic peaks for carboxylate anions, with no peaks for ADH, which indicates the 
 
Figure 2.2 FTIR spectra of 1.5% alginate_MES_5.5_ADH crosslinked with CaCl2, EDC or 
both CaCl2 and EDC. Crosslinking of alginate with CaCl2 didn’t change the spectra, while 
further addition of EDC into the CaCl2 crosslinked alginate led to the characteristic peaks 
for amide bonds at 1660 cm
-1
, and 1550 cm
-1 
(red and blue arrows, respectively). 
Crosslinking of alginate, ADH with EDC also resulted in the amide formation despite that 
there were carboxyl groups remaining indicated by the black dash line. 
 38 
 
efficiency of the dialysis. Ionically crosslinked with CaCl2, the mixture had similar FTIR 
spectrum profile as that of the non-ionically crosslinked one. Addition of EDC to 
alginate/hyaluronic acid mixture without ADH led to ester bond formation as well as some amide 
formation, whereas addition of ADH resulted in more amide bonds and fewer ester bonds. This 
was consistent with the result of the crosslinking of hyaluronic acid with ADH as described 
above.  
 
 
Figure 2.3 FTIR spectra of 1.5% alginate_0.375% hyaluronic acid_ADH_PH mixtures 
crosslinked with CaCl2, EDC or both CaCl2 and EDC under mixing or dispensing 
conditions. There was amide formation when EDC was added to the alginate/hyaluronic 
acid mixture and the reaction efficiency was increased when ADH was further 
incorporated. Also, the covalent modification was made to the alginate_hyaluronic 
acid_ADH mixture with the presence of both CaCl2 and EDC. Black dash line indicated 
the characteristic peak at 1600 cm
-1
 for carboxylate anions, red and blue arrows 
represent the characteristic peaks at 1660 cm
-1
 and 1550 cm
-1 
for amide bonds.  
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Also, there was amide formation in the group of alginate_hyaluronic acid_ADH_PH 
immersed within crosslinker solution of 100 mM CaCl2 and 100 mM EDC. However, peaks in 
the range of 1400 cm
-1
 to 1750 cm
-1
 are not evident and decent. This was probably due to the 
presence of the carboxylate anions in the ionically-crosslinked alginate, which might ruffle the 
spectrum. Also, it is possible that CaCl2 might disturb the amide formation as both ionic and 
covalent crosslinking are aimed at the carboxyl groups. Primary results indicated that CaCl2 
didn’t affect on the amide formation of hyaluronic acid with ADH. Thus, it is likely that CaCl2 
can influence on the covalent crosslinking through gelation of alginate with CaCl2. 
FTIR spectra of alginate_hyaluronic acid_ADH_PH mixtures crosslinked by 100 mM 
EDC with varying concentrations of CaCl2 were shown in Figure 2.4. Though it is difficult to 
quantify the amide formation using FTIR spectroscopy measurement, Figure 2.4 demonstrates 
that amide formation was dependent on the concentration of CaCl2. With less CaCl2 added for 
ionic crosslinking, there was more amide bond formation concluded from the relative amount of  
amide II band (blue dash line) and amide I band (red dash line) to the carboxylate anions (black 
dash line). Ionic crosslinking of alginate with CaCl2 is dependent on the concentration of CaCl2 
and gelating time. The more CaCl2 applied and the longer time it is allowed for ionic 
crosslinking, the fewer carboxylate groups in the alginate are left for amide formation, which 
takes a longer time. Thus, it is necessary to control the extent of ionic crosslinking so as to 
permit more covalent modification. And this can be done through limiting the CaCl2 amount and 
the crosslinking time for ionic modification. On the other hand, ionic crosslinking of alginate in 
the alginate/hyaluronic acid mixture should be strong enough to provide the structural support 
for the 3D scaffold during the dispensing process. 
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Concentration of EDC also affected the amide formation, as shown in Figure 2.5: there 
was more amide bond formation with higher concentration of EDC. 50 mM EDC was excessive 
to crosslink the carboxylate groups in the alginate_hyaluronic acid_ADH_PH. As discussed in 
Chapter 1, excessive EDC leads to more side reaction of N-acylurea formation. However, 
without homogenization, the covalent crosslinking of alginate/hyaluronic acid was slow and the 
chance of reagent molecules coming across was quite limited. Thus, higher concentration of 
EDC is probably needed for more covalent crosslinking of alginate/hyaluronic acid mixture.  
Figure 2.4 Effect of CaCl2 concentrations on the covalent crosslinking of 1.5% 
alginate_0.375% hyaluronic acid_ADH_PH. With the increase of concentration of CaCl2 
solution, there seemed to be fewer amide bonds, as indicated by the characteristic peaks at 
1660 cm
-1
(red dash line), and 1550 cm
-1 
(blue dash line). And higher concentration of 
CaCl2 masked the FTIR spectrum, with the undistinguishable peaks for different chemical 
bonds. Black dash line indicated the characteristic peak at 1600 cm
-1
 for carboxylate 
anions. 
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Next, pH value of the reaction was investigated since the respective pH adjustment of 
alginate and hyaluronic acid solution was troublesome and time-consuming. It would be easier 
that both alginate and hyaluronic acid can be dissolved in the same buffer, while ensuring the pH 
value to be high enough to non-precipitate alginate and low enough to allow the chemistry to 
work. At first attempt, MES buffer at pH of 5.5 was proposed to dissolve both alginate and 
hyaluronic acid, after which ADH would be added. However, since the MES buffer is effective 
within the pH range of 5.5 to 6.7 and addition of ADH would increase the pH value. And the 
primary experimental result shows that mixtures with a lower pH value crosslink sooner. Thus, 
attempt was tried to prepare MES buffer at pH of 4 initially while addition of ADH makes the 
final pH value equal 5.5.  
Figure 2.5 Effect of EDC concentrations on the covalent crosslinking of 1.5% 
alginate_0.375% hyaluronic acid_ADH_PH. There was more amide formation when EDC 
was added at a higher concentration. Black dash line indicated the characteristic peak at 
1600 cm
-1
 for carboxylate anions; red and blue dash lines represented the peaks at 1660 
cm
-1 
and 1550 cm
-1
 for amide bonds. 
 
 42 
 
 
Comparison of amide formation with different preparation methods of hyaluronic acid 
hydrogel and alginate/hyaluronic acid hydrogel is shown in Figure 2.6. And we can find that 
(a) 
(b) 
Figure 2.6 Effect of pH value on the covalent crosslinking of (a) hyaluronic acid, and (b) 
alginate/hyaluronic acid mixture. (a)More amide bonds were formed for hyaluronic acid 
at a lower pH as indicated by the relatively more peak absorption at 1533 cm
-1
; (b)No 
significant difference of amide formation was observed for alginate/hyaluronic acid 
mixutures reacted at different pH values. 
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both methods lead to the formation of amide bonds of hyaluronic acid with ADH, but the 
crosslinking speed is quicker at pH of 4 and there seems to be more amide bond formation at the 
lower pH value (Figure 2.6 (a)). As for the alginate/hyaluronic acid mixture, the hydrogel 
formation is sooner in the group of alginate_hyaluronic acid_ADH_PH group, which has the pH 
value of 5. The pH value of alginate_hyaluronic acid_MES_4_ADH mixture was around 5.5, and 
the reaction rate was slower. From the FTIR spectra, we cannot conclude whether there was 
significant difference of amide formation between these two groups.  
The effect of pH value on the EDC-mediated amide formation has been investigated by 
others, and the result shows that pH value of 5.5 leads to a most efficient conjugation of peptide 
into the biomaterial [137]. However, with different reaction reagents having different pKa (acid 
dissociation constant) values, it is possible that the pH value of a particular reaction is unique 
and this could be achieved by measuring the conjugation efficiency at different pH values. Since 
the reaction is more favorable under lower pH values, the preparation method of respective pH 
adjustment of hyaluronic acid_ADH_4 and alginate_MES solution before mixing together was 
applied for the biocompatibility test in Chapter 3.   
 
2.4 Conclusions 
There are covalent crosslinking of alginate/hyaluronic acid mixture with ADH in 
presence of CaCl2, and the chemical modification is dependent on the concentration of EDC, 
CaCl2 and pH value of the reaction. Effect of the pH value on the covalent crosslinking 
efficiency is probably due to the fact that the amide formation requires both ionized carboxyl 
groups and disassociated protons (as indicated in Figure 1.5), which can be obtained through 
maintaining the pH within the range of 3.5 to 4.5 [79]. It still remains to be determined whether 
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the hyaluronic acid in the mixture was covalently crosslinked. The present research shows that 
alginate, after crosslinking with CaCl2, can further crosslink with ADH by EDC, which might 
delay the loss of the mechanical strength of alginate in vivo. And the incorporation of crosslinked 
hyaluronic acid may further increase the in vivo residence time. For this, in vivo biodegradation 
study of alginate/hyaluronic acid hydrogels may shred a light on this.   
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 CHAPTER 3 Biocompatibility of Alginate/Hyaluronic acid Hydrogels  
3.1 Introduction 
Covalent crosslinking of alginate/hyaluronic acid mixture with ADH at presence of EDC 
and CaCl2 were examined, yet it remains to check the biocompatibility of the composite 
hydrogels for Schwann cells, which are proven to play a key role in both peripheral nerve and 
spinal cord regeneration. Thus, it is interesting to investigate whether the concentration of 
alginate and hyaluronic acid have an effect on the Schwann cell viability and growth. Besides, 
the effects of the covalent modification of the alginate/hyaluronic acid substrates and the 
concentration of hyaluronic acid incorporated were also studied so as to find the proper 
composite substrate for Schwann cell culture, which will be promising for SCI repair. 
 
3.2 Materials and Methods 
3.2.1 Schwann Cell Culture 
In this study, Schwann cells (RSC 96, CRL-2765, passage number from 14 to 22) 
purchased from ATCC (American Type Culture Collection ATCC, Manassas, VA) were used for 
the MTT (3-(4, 5-Dimethylthiazol-2-yl)-2, 5-diphenyltetrazolium bromide, a yellow tetrazole) 
assay to determine the biocompatibility of the composite hydrogels. Schwann cells were cultured 
in standard Dulbecco's Modified Eagle Medium (DMEM), 10% fetal bovine serum (FBS) 
(Invitrogen Co, Carlsbad, California, CA, USA), and 1% antibiotics 
(penicillin/streptomycin/amphotericin-B) on the 10-cm tissue culture dish at 37°C in a 5% CO2, 
relatively humidified incubator. Cells were passed at 80-100% confluence using 0.05% 
Trypsin/ethylenediaminetetraacetic acid (EDTA) (Invitrogen). And cell counting of Nigrosine 
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dye staining were performed with a hemocytometer. Before cell seeding, the cells were 
resuspended in fresh medium to the desired cell density. 
 
3.2.2 Substrate Preparation  
Low viscosity sodium alginate, molecular weight range 12,000~80,000 Da, mannuronic 
acid 61% and guluronic acid 39% was purchased from Sigma Aldrich Canada. Calcium chloride 
(Sigma, St. Louis, MO) was used as the crosslinker for sodium alginate. Hyaluronic acid sodium 
salt (MW 26-27 MDa) was bought from Shandong Freda Biopharm Co., Ltd. (Freda, Jinan, 
Shandong, China). ADH, MES buffer with useful pH range of 5.5-6.7, and EDC were all 
purchased from Sigma Aldrich Canada.  
Two dimensional (2D) films of double-crosslinked alginate/hyaluronic acid hydrogel 
with different volume ratios of 3% alginate_MES_5.5 and 0.75% hyaluronic acid_ADH_4 were 
formed in 24-well tissue culture plates. Specifically, 100 µL of the alginate_hyaluronic 
acid_ADH_PH mixture was poured evenly into each well of the plate and 200 µL of 50 mM 
EDC_50 mM CaCl2 crosslinker solution was applied on the top of the mixture. For the group of 
3% alginate, only CaCl2 crosslinking was applied, while for the group of 0.75% hyaluronic acid, 
merely EDC crosslinker solution was used. The crosslinking process was allowed to proceed for 
6 hours or 20 hours at room temperature before rinsed extensively with phosphate buffer solution 
(PBS) buffer for 5 times, 5 mins per time. The crosslinked substrates were then sterilized with γ-
radiation (dose rate: 7.13 Gy per minute) for 20 hours. Substrates made from uncrosslinked 
alginate or hyaluronic acid as well as crosslinked 20%-80% (V/V) alginate/hyaluronic acid 
hydrogels coated with 300 µL/well 100 µg/mL poly-l-lysine hydrobromide (PLL) (mol wt 
30,000-70,000, Sigma) at 4°C overnight were used as controls. 
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Schwann cell culture on the 1.5% alginate with different amounts of hyaluronic acid was 
carried out to investigate the effect of concentration of hyaluronic acid on the Schwann cell 
viability and growth. Comparison of just ionic crosslinking with both ionic and covalent 
crosslinking on the cell number was also studied. In detail, mixtures of 1.5% alginate with 0%, 
0.375%, 0.50% and 0.75% hyaluronic acid were prepared by dissolving the alginate, hyaluronic 
acid and ADH (3.75%, wt%) in 100 mM MES buffer at pH value of 4, which resulted in a pH 
value of 5.5 as mentioned in Chapter 2. 20 µL of the mixtures was then spread evenly in each 
well of a 96-well tissue culture plate and centrifuged at 4000 rpm/min for 5 mins. The prepared 
films were then left in air overnight to air dry. After drying, 80 µL of 50 mM CaCl2 was applied 
in each well on the top of the film for the ionically-crosslinked groups. For the double-
crosslinked ones, 80 µL of 50 mM CaCl2_100 mM EDC was applied in each well on the film 
and crosslinked for 24 hours. Rinsed three times with double distilled water, the films were then 
immersed in 70% ethanol overnight to sterilize the substrates. After removing the ethanol, the 
substrates were rinsed twice with double distilled water and one more time with DMEM with 1% 
antibiotics.  
 
3.2.3 Cell Seeding and MTT Assay 
MTT assay is used to assess the cytotoxicity of alginate/hyaluronic acid hydrogels. The 
reduced insoluble, dark purple formazan of MTT by living cells can be solubilised by dimethyl 
sulfoxide into a colored solution, whose absorbance will be measured spectrophotometrically 
[138]. Thus, the cell number is correlated with the absorbance of the formazan reagent.  
For the experiment studying the effect of concentration of alginate and hyaluronic acid on 
Schwann cell survival and growth, Schwann cells were seeded on the prepared 2D substrates at a 
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density of 100,000 cells/mL and 1 mL of the cell suspension was placed in each well of 24-well 
tissue culture plates. Cells were incubated in the 5% CO2, 95% air, 37°C, humidified incubator 
and motored microscopically every day by Zeiss Axiovert 100 (Zeiss, Germany) supplemented 
with Retiga EXi Fast 1394 CCD Camera (QImaging, CA). MTT assay was carried out according 
to the protocol after 2 days’ incubation at which the cells were about 95% confluent. Specifically, 
5 mg/mL stock solution of MTT (Sigma) was prepared in 10 mM sterile PBS and 120 µL of 
MTT solution was added to each well. After incubation at 37°C for 3.5 hrs, media were carefully 
removed without disturbing the cells. 800 µL of dimethyl sulfoxide (Sigma) was added to each 
well and the plate was agitated on an orbital shaker at 150 rpm for 5 mins. To eliminate the 
interference of the substrate absorbance of the light, the soluble colored solution was removed to 
a clean 96-well tissue culture plate and the plate was read by a LISA reader (Spectra Max 340, 
Molecular Device Inc., CA, USA) at 560 nm with reference filter of 670 nm.  
For the experiment studying the effect of covalent crosslinking and concentration of 
hyaluronic acid incorporated on the cell number of Schwann cells, 1500 cells was placed in each 
well of the 96-well tissue culture plate and incubated for 2 days, after which the MTT assay was 
carried out according to the protocol to evaluate the cell number of Schwann cells on the 
different substrates. The amount of MTT is 5 mg/mL and 20 µL/well. The incubation time is 1 hr. 
 
3.2.4 Statistical Analysis 
Measured values are expressed as means ± standard deviation. Levels of significance for 
comparing mean values of absorbance in the MTT assay were calculated using one-way 
ANOVA with Turkey post test.  All calculations were made using GraphPad Prism 5.0. 
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3.3 Results and Discussions 
Figure 3.1 and Figure 3.2 show the Schwann cell morphology after 2 days’ incubation on 
the 2D double-crossliked alginate/hyaluronic acid hydrogels. The images were taken at same 
illumination and photography conditions. The results showed that Schwann cells on the 
alginate/hyaluronic acid hydrogels (Figure 3.1 (c)) and crosslinked hyaluronic acid films (Figure 
3.1 (d)) had spherical-shaped morphology, with cells assembling in clusters. In contrast, 
Schwann cells on the tissue culture plate and PLL-treated tissue culture plate (Figure 3.1 (a) and 
Figure 3.1 (b), respectively) showed typical spindle-shaped morphology. This indicated that the 
substrates were even less preferable than the surrounding cells. This can be explained as the non-
adhesive properties of alginate and hyaluronic acid. Compared to the 100% hyaluronic acid 
hydrogel, alginate/hyaluronic acid hydrogels seemed to be more favorable for the Schwann cell 
attachment. The uncrosslinked alginate was quite favorable for the cell attachment as shown in 
Figure 3.2 (b), while the uncrosslinked hyaluronic acid film did not permit the attachment of the 
cells (Figure 3.2 (a)). PLL treatment on the 20%-80% alginate/hyaluronic acid hydrogels, to 
some extent, enhanced the adhesion of Schwann cells though the attachment was not as good as 
the tissue culture plate or the uncrosslinked alginate films. 
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            Figure 3.3 showed the MTT assay results for the number of Schwann cells after 2 days’ 
incubation on the alginate/hyaluronic acid substrates double-crosslinked for 6 hours (a) or 20 
hours (b). There was significant difference between control groups (Schwann cells on tissue 
culture plate, PLL-treated tissue culture plate, uncrosslinked hyaluronic acid and alginate films) 
and experimental groups (alginate/hyaluronic acid hydrogels with different concentrations of 
alginate and hyaluronic acid; and PLL-coated 20%-80% alginate/hyaluronic acid hydrogels), P < 
0.05. 
Figure 3.1 Schwann cell morphology after 2 days’ culture on (a) tissue culture plate; (b) 
PLL-coated tissue culture plate; (c) 20%-80% alginate/hyaluronic acid hydrogels; and (d) 
100% hyaluronic acid hydrogels. Scale bars: a, b, c, d=100 µm. 
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The numbers of Schwann cells on the alginate/hyaluronic acid hydrogels crosslinked for 
6 hours with different volume ratios were not significantly different except the group of 100% 
hyaluronic acid hydrogels with hydrogels at volume ratios of 20%:80%, 50%:50% and 30%:70%. 
The relatively low number of Schwann cells on the EDC crosslinked hyaluronic acid hydrogels 
compared to the other groups may be due to the unfavorable adhesion of Schwann cells onto the 
hyaluronic acid substrate compared to the alginate/hyaluronic acid hydrogels and the barely 
attached cells were carelessly removed during the MTT assay. The inhibitory effect of 
Figure 3.2 Schwann cell morphology after 2 days’ culture on (a) uncrosslinked hyaluronic 
acid films, (b) uncrosslinked alginate films, (c) PLL-coated 20%-80% alginate/hyaluronic 
acid hydrogels and (d) 20%-80% alginate/hyaluronic acid hydrogels. Scale bars: a, b, c, 
d=100 µm. 
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hyaluronic acid with high molecular weight on cell proliferation may also cause the relatively 
low cell number. Still, from the morphology of the hydrogels prepared, hyaluronic acid 
hydrogels had a stronger mechanical property in comparison with other alginate/hyaluronic acid 
hydrogels or alginate hydrogels. This may also lead to the discrepancy of cell number on the 
hyaluronic acid hydrogels with the composite hydrogels.               
 
 
(a) 
(b) 
Figure 3.3 MTT result for the number of Schwann cells on the double-crosslinked 
alginate/hyaluronic acid hydrogel films with different volume ratios of 3% alginate and 
0.75% hyaluronic acid for 6 hours (a) and 20 hours (b). Error bars represent the standard 
deviation; *p < 0.05, **p < 0.001, ***p < 0.0001 
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Compared to the non-PLL-coated 20%-80% alginate/hyaluronic acid hydrogels, the PLL-
treated ones had significantly more Schwann cells (P < 0.001). For the hydrogels crosslinked for 
20 hours, there was no significant difference in the cell number of Schwann cells between 
different experimental groups, P > 0.05. This indicates that the composite hydrogels have a 
comparable biocompatibility as the individual biomaterial. 
Experiment into the effect of covalent crosslinking on the number of Schwann cells was 
carried out and the result indicated that there was significant difference between the ionically 
crosslinked alginate/hyaluronic acid hydrogels with their correspondent double-crosslinked ones 
as shown in Figure 3.4. But there was no significant difference in cell number between the group 
of 1.5% alginate_0% hyaluronic acid_CaCl2 with that of 1.5% alginate_0% hyaluronic 
acid_CaCl2, EDC, though there were fewer cells on the latter substrate. 
 
Figure 3.4 MTT result of Schwann cells after 2 days’ culture on the ionically-crosslinked 
and double-crosslinked alginate/hyaluronic acid hydrogels. Error bars represent the 
standard deviation; **p < 0.001, ***p < 0.0001. 
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For the effect of hyaluronic acid’s concentration on the number of Schwann cells on the 
CaCl2 crosslinked alginate/hyaluronic acid substrates, there was no significant difference in cell 
number except the group of 1.5% alginate/0.5% hyaluronic acid with that of 1.5% 
alginate/0.75% hyaluronic acid, with fewer cells in the latter group. This probably is due to the 
fact that the high molecular weight hyaluronic acid inhibits the cell proliferation [139, 140]. On 
the other hand, there were no significant differences among other groups with lower 
concentrations of hyaluronic acid (0%, 0.375%, and 0.5%). This was possibly attributed to the 
non-covalently incorporated hyaluronic acid, which might escape from the scaffolds into the 
surrounding environment. In addition, the difference of cell number on these ionically-
crosslinked alginate/hyaluronic acid substrates with the group of tissue culture plate was not 
statistically significant, indicating that the ionically-crosslinked alginate/hyaluronic acid 
substrates are comparable to the tissue culture plate and thus are quite suitable for Schwann cell 
culture.  
When comparing the ionically-crosslinked 1.5% alginate/0.375% hyaluronic acid, 1.5% 
alginate/0.5% hyaluronic acid and 1.5% alginate/0.75% hyaluronic acid to their respective 
double-crosslinked ones, we can find that there were all significant differences. However, no 
significant difference was found between the groups of ionically-crosslinked 1.5% alginate 
substrate with the one of double modification. This means that the covalent crosslinking of 
alginate with ADH by EDC did not affect much on the biocompatibility of the alginate hydrogels. 
The non-complete covalent crosslinking didn’t lead to much physical and mechanical change of 
the substrates. If these assumptions are applicable to the alginate/hyaluronic acid hydrogels 
similarly, then the significant differences between the ionically-crosslinked composite hydrogels 
with their corresponding double-crosslinked ones are attributable to the fact that the incorporated 
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hyaluronic acid were covalently crosslinked by ADH under the function of EDC, which might 
affect on the mechanical properties of the substrates and therefore influence on the cell number.  
Also, it was found that there were significantly fewer cells on the 1.5% alginate/0.75% 
hyaluronic acid_CaCl2, EDC substrate in comparison with the 1.5% alginate/0% hyaluronic 
acid_CaCl2, EDC. This was probably because hyaluronic acid inhibited cell proliferation or the 
covalent crosslinking of hyaluronic acid resulted in the non-favorable substrate for cell survival 
and growth.  
When comparing the double-crosslinked alginate/hyaluronic acid substrates 
(1.5%/0.375%, 0.50%, and 0.75%) to the positive control (tissue culture plate), we can conclude 
that the double-crosslinked composite hydrogels did not permit as much Schwann cell survival 
and growth as the tissue culture plate. As discussed above, the ionically-crosslinked 
alginate/hyaluronic acid substrates were comparable to the tissue culture plate in allowing 
Schwann cell survival and growth. Thus, we can conclude that the ionically-crosslinked 
alginate/hyaluronic acid substrates are more preferable to the double-crosslinked ones in 
Schwann cell culture.  
 
3.4 Conclusions 
From the MTT assay results for Schwann cell viability and growth, it is observed that 
both the double-crosslinked and ionically-crosslinked alginate/hyaluronic acid hydrogels allow 
for the Schwann cell survival and growth, indicating the potential of this composite biomaterial 
as a matrix for Schwann cells and neurite outgrowth of DRG neurons. There was no significant 
difference in cell number among the alginate/hyaluronic acid hydrogels with different volume 
ratios of 3% alginate and 0.75% hyaluronic acid. In terms of the number of Schwann cells, 
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covalent crosslinking and high concentration of hyaluronic acid seemed to be inhibitory for 
Schwann cell survival and growth. Thus, hydrogel of ionically-crosslinked 1.5% alginate/0.375% 
hyaluronic acid or 1.5% alginate/0.5% hyaluronic acid is most suitable for Schwann cell culture. 
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CHAPTER 4 Fabrication and Mechanical Characterization of 
Alginate/Hyaluronic Acid Scaffolds 
4.1 Introduction 
Bioengineered scaffolds with highly interconnected pore networks show promise for SCI 
repair. Alginate has been used successfully to fabricate scaffolds with reproducible 
microstructure using the dispensing-based rapid prototyping technique [141]. Unfortunately, the 
alginate scaffolds show limited interaction with mammalian cells due to the absence of receptors 
required for binding. Hyaluronic acid, which has been shown to promote robust neurite 
outgrowth, is incorporated in this study.  
In Chapter 3, we have looked into the biocompatibility of the alginate/hyaluronic acid 
substrates, either ionically crosslinked or double-crosslinked ones. It was found that the 
ionically-crosslinked alginate/hyaluronic acid hydrogels permitted more survival and growth of 
Schwann cells. However, in order to fabricate 3D scaffolds, it is necessary to consider the 
feasibility to produce 3D scaffolds from the composite biomaterial by the dispensing-based rapid 
prototyping system. Concentration of hyaluronic acid affects on the fluid behavior of the 
dispensed biomaterial, and therefore influences on the 3D scaffold fabrication process. Thus, the 
ionically-crosslinked alginate/hyaluronic acid hydrogels with different concentrations of 
hyaluronic acid were used for the scaffold fabrication. Concentration of ionic crosslinker 
solution (CaCl2) was also studied to check its effect on the strand profile in terms of strand 
diameter, linearity, and connectivity between layers.  
Mechanical properties of the hydrogels are very important as the implanted scaffold 
should be strong enough to provide necessary mechanical support while not too hard to damage 
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the surrounding native tissue. For this, this chapter also presents the mechanical characterization 
of the 3D alginate/hyaluronic acid hydrogel scaffolds.  
 
4.2 Materials and Methods 
Low viscosity sodium alginate, molecular weight range 12,000~80,000 Da, mannuronic 
acid 61% and guluronic acid 39% was purchased from Sigma Aldrich Canada. Calcium chloride 
(Sigma, St. Louis, MO) was used as the crosslinker for sodium alginate. Hyaluronic acid sodium 
salt (MW 26-27MDa) was bought from Shandong Freda Biopharm Co., Ltd. (Freda, Jinan, 
Shandong, China).  
 
4.2.1 Preparation of Alginate/Hyaluronic Acid Mixture 
Stock solution of 6% (w/v) sodium alginate and 2% (w/v) hyaluronic acid were used to 
prepare four alginate/ hyaluronic acid mixtures with the final alginate concentration of 1.5% and 
final hyaluronic acid concentrations of 0%, 0.375%, 0.5% and 0.75%. These gel mixtures were 
proceeded for viscosity measurement, fabrication and mechanical test. CaCl2 solutions of 10 
mM, 30 mM, 50 mM, 75 mM, 100 mM and 150 mM were used as the ionic crosslinking media 
for alginate/hyaluronic acid mixtures. Such concentrations were chosen to validate whether the 
decrease of crosslinker solution concentration would limit the crosslinking speed and density, 
which might serve to solve the problem of detachment between different layers during 
dispensing. Also, as crosslinking extent of the alginate would lead to shrinkage or swelling of the 
dispensed struts, the variation of CaCl2 concentration might facilitate the fabrication of 3D 
scaffolds with controllable microstructure. 
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4.2.2 Viscosity Measurement 
The rheological properties of prepared alginate/hyaluronic acid mixtures were measured 
by a rheometer (Brookfield DV-III+ Programmable rheometer, Brookfield, Middleboro, MA), 
shown in Figure 4.1.  
 
This rheometer has a cone and plate structure with the shear rate controlled via 
programming. The rheometer also provides the ability to collect and record the data during the 
rheological tests. In the present study, a CP 41 spindle was selected for use, which required a 
sample volume of 2 mL. After zeroing and calibration of the rheometer, the flow behavior of 
alginate/hyaluronic acid mixtures was measured at varying shear rates via the control of the 
spindle rotation speed sweeping from 10 RPM to 250 RPM in 30 RPM increments. Only data 
with the torque value ranging from 10% to 100% was considered to be effective data. All the 
measurements were done once as the repeatability of the instrument was proven high. Shear 
(a) (b) 
Figure 4.1 (a) Wells/Brookfield DV-III+ Cone/Plate rheometer; (b) sample cup spindle for 
the rheometer. 
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stress-shear rate curves as well as viscosity-shear rate curves were obtained to characterize the 
flow behavior of different mixtures and the power law was applied to fit the curves: 
                                                            K
n
                                              (Eq. (4.1)) 
Where τ is the shear stress, τ0 is the yield stress, Κ is the consistency index,  is the shear rate 
(the velocity gradient perpendicular to the plane of shear), and n is the flow behavior index.  
 
4.2.3 Fabrication of Multilayer Scaffolds  
4.2.3.1 Scaffold Fabrication by the Adapted Fluid Dispensing System 
For the fabrication of 3D hydrogel scaffolds, the dispensing-based rapid prototyping 
system adapted from a typical commercial fluid dispensing system (C0720M, Asymtek), shown 
in Figure 4.2, was applied. The pressured air in the pneumatic dispenser drives the fluid flow in 
the syringe through a small-sized dispensing nozzle. And with the personal computer to control 
the dispenser, position and temperature, this system enables the construction of 3D scaffolds 
with reproducible, controllable and complex microstructure. In this study, aqueous mixtures of 
1.5% alginate with 0%, 0.375%, 0.50% and 0.75% hyaluronic acid were dispensed layer by layer 
through 250 µm SmoothFlow nozzle tip into CaCl2 crosslinking solution for gel formation. 
Unfortunately, with parameters such as air pressure, needle size, nozzle velocity, flow behavior 
of dispensed biomaterials, as well as the initial nozzle height from the crosslinking solution, it is 
quite difficult to control the scaffold microstructure. To obviate the time-consuming process of 
adjusting so many parameters for scaffold fabrication, model of the strut diameter was applied. 
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Diameter of the dispensed struts is dependent on the flow rate, nozzle velocity, swelling 
rate of the hydrogel strands. Ignorant of the effect of swelling, the relationship between the strut 
diameter with the flow rate and nozzle velocity can be represented as Eq. (4.2) 
                                                              D=                                                      (Eq. (4.2)) 
Where Q is the volume flow rate (mL/s) and v is the nozzle deposition velocity.  
To obtain deposited struts with diameters equal to the nozzle inner diameter, the velocity 
of nozzle (defined as nozzle deposition velocity) can be determined in Eq. (4.3) 
                                                              v                                                      (Eq. (4.3)) 
To avoid mechanical vibration of the system caused by high speed nozzle movement, the 
nozzle deposition velocity was limited to 5 mm/s to 20 mm/s. Thus, with a predefined nozzle 
deposition velocity and nozzle diameter, flow rate at which the dispensed strut diameter equals to 
Figure 4.2 Adapted commercial fluid dispensing machine: (a) horizontal view of the whole 
system; (b) close-up view of the dispensing component. 
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the nozzle inner diameter can be calculated according to Eq. (4.3). And with the help of the mass 
flow rate measurement function provided by the dispensing system, air pressure was then 
adjusted to get the flow rate needed. Table 4.1 summarizes the calculated and experimental flow 
rate and strut diameter correspondent to different nozzle deposition velocities for 1.5% 
alginate/0.75% hyaluronic acid.  
 
Table 4.1 Calculated and Experimental Flow Rate, and Strut Diameter Correspondent to 
Different Nozzle Deposition Velocities for  
1.5% Alginate/0.75% Hyaluronic Acid 
Nozzle Deposition 
Velocity (mm/s) 
Calculated 
Volume Flow 
Rate 
Calculated Mass 
Flow Rate 
Experimental 
Mass Flow Rate 
Calculated 
Strut Diameter 
 
5 mm/s 0.25 µl/s 0.244 mg/s 0.26 mg/s 260.52 µm 
10 mm/s 0.50 µl/s 0.488 mg/s 0.52 mg/s 260.65 µm 
15 mm/s 0.75 µl/s 0.731 mg/s 0.76 mg/s 257.29 µm 
20 mm/s 1.00 µl/s 0.975 mg/s 1.00 mg/s 266.85 µm 
 
To overcome the surface tension of the first layer, the initial level of CaCl2 solution was 
lowered to just cover the Petri dish surface. For the following layers, the level of CaCl2 solution 
was increased after each layer by an increment equal to the layer thickness. The amount of the 
added CaCl2 solution each layer can be calculated as Eq. (4.4) 
                                                V                                                     (Eq. (4.4)) 
Using the glass tissue culture Petri dish (D=100 mm, h=15 mm), the volume of the 
crosslinking solution added for each layer will be 2 mL for 250 µm nozzle tip. While dispensing, 
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the initial needle height from the Petri dish bottom was adjusted to obtain the strands that are 
uniform and straight with the diameter approximate to 250 µm.  
CaCl2 concentration affects the crosslinking speed and density of alginate, and thus is 
important for the attachment of scaffold layers and the control of strand diameter. The 
concentration of CaCl2 was varied from 10 mM to 150 mM for each mixture to examine its 
influence on the fabrication of scaffolds, which was characterized in terms of strut diameter, 
linearity and connectivity between layers. 
To quantify the effect of hyaluronic acid’s addition and CaCl2 crosslinker concentration 
on the feasibility and manufacturability of scaffold fabrication, top and front view images of four 
4-layer scaffolds from each group were taken microscopically to visually show the strand profile 
as well as the intersectional part. Average strut diameter was determined by averaging the 
diameters of 4 randomly chosen struts using the equipped image software. The 4-layer scaffolds 
(n=5) were then placed in 3 mL of CaCl2 solution for 24 hours to validate the attachment 
between different layers. The criteria is that scaffolds with straight line of predefined diameter, 
less fusion but more connection between layers are better.  
 
4.2.3.2 Fabrication of Scaffold by 3D BioplotterTM System 
The adapted fluid dispensing system is not sophisticated, leading to the uncontrollable 
and non-repetitive results. Because of this, the 3D Bioplotter
TM
 system was used instead to check 
the feasibility of fabricating 3D scaffolds with controllable and repetitive microstructure from 
composite biomaterial. The 3D-Bioplotter™ (EnvisionTEC, 4th generation) is a proper rapid 
prototyping tool for the 3D scaffold fabrication with defined inner and outer structure. It handles 
a very wide range of biomaterials, from soft hydrogels for soft tissue regeneration over melting 
polymers such as polycaprolactone to hard ceramics and metals. It offers an axis resolution of 
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0.001 mm and a needle sensor resolution of 0.001 mm, making the dispensing process quite 
repetitive and controllable. One another advantage of this rapid prototyping system is that it is 
particularly designed to work in sterile environment in a laminar flowbox, making the fabrication 
of scaffolds with living cells possible.  
The 3D-Bioplotter™ is delivered together with a personal computer workstation which 
operates and monitors the system. When fabricating, a 3D CAD model was first established and 
then transferred to the equipped personal computer and processed by the Bioplotter
TM
 Software 
Package. The 3D Bioplotter
TM
 then receives the preprocessed data and starts building the 3D 
scaffolds, which is still monitored by the Bioplotter
TM 
software.  
The low temperature dispensing cartridge was used in this experiment to load the 
dispensing materials: composite material of 1.5% alginate/0.375% hyaluronic acid. After 
calibrating the X, Y, Z position and the needle height, trials were made to find the suitable air 
pressure and dispensing velocity to obtain desired strand diameter. Once these parameters were 
determined, the fabrication of 3D scaffolds started. It was found that if the composite biomaterial 
was dispensed into the CaCl2 solution, the dispensed strands floated on the surface of the solution 
and the strands were curved. Thus, attempts were tried to dispense 2-layer scaffold onto the Petri 
dish first, after which very little amount of CaCl2 solution was applied carefully onto the 2-layer 
scaffold to let the crosslinking take place. After that, excess CaCl2 solution was removed using 
the Kimwipe without disturbing the integrity of scaffold structure. This was done to avoid the 
surface tension caused by the material with the CaCl2 solution. Repeat the same procedure every 
2 layers before the final scaffold was completed. The fabricated scaffolds were then imaged 
microscopically to examine the internal and external structures. 
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4.2.4 Mechanical Test 
In this study, 50 mM CaCl2 was chosen for the crosslinking of the four aqueous 
alginate/hyaluronic acid mixtures for uniaxial compression test to study the effect of hyaluronic 
acid’s addition on the mechanical property. Alginate/hyaluronic acid mixtures and 100 mM 
CaCl2 solution were poured into custom-made cylindrical Teflon molds (10 mm diameter × 20 
mm length) at a volume ratio of 2:1 to crosslink for 12 hours at room temperature. The hydrogels 
(n=4) was then removed and placed in large quantity of 50 mM CaCl2 solution for additional 12 
hours. The cylindrical hydrogels scaffolds were then cut at both ends to obtain sample size of 10 
mm diameter × 10 mm length. Sample sizes of diameter and length were measured in triplet 
before applying compressive force.  
The mechanical tests were all performed on a desktop measurement system, 
ElectroForce® 3100 test instrument (Bose Corporation, ElectroForce® Systems Group, USA), as 
shown in Figure 4.4. The instrument can provide high resolution of a minimum 6 mN 
Figure 4.3 (a) 3D Bioplotter
TM
 system and (b) examples of the 3D scaffolds fabricated from 
different materials using the 3D Bioplotter
TM
 system. 
 
(a) (b) 
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controllable peak-to-peak force and minimum 0.0015 mm controllable peak-to-peak 
displacement. Thus, this instrument is well suited for the tissue mechanics research, micro-
indentation of cartilage and other soft tissue, dynamic mechanical analysis of tissues, elastomers 
and other soft materials. Apply a ramp displacement generated by the WinTest® digital control 
system at a constant rate of 0.083 mm/s (5 cm/min) on the specimens to provide a compressive 
force till a 20% strain (2.0 mm) was achieved. Collect the data of load and displacement, from 
which the stress-strain curves can be obtained. Such mechanical properties as compressive 
elastic modulus, and tangent modulus were then determined from the stress-strain curves. 
 
 
 
 
Figure 4.4 The ElectroForce® 3100 test instrument: a) the hardware of the instrument 
including the WinTest digital control system, load sensor, a mover and a chamber; b) the 
chamber structure, providing a sterilized and isolated environment as a bioreactor for the 
sample during the mechanical test. 
 67 
 
4.2.5 Statistical Analysis  
Measured values are expressed as means ± standard deviation. Levels of significance 
were calculated using one-way ANOVA with Turkey post test. All calculations were made using 
GraphPad Prism 5.0. 
 
4.3 Results and Discussions 
4.3.1 Flow Behavior 
The relationship of shear stress with shear rate for different mixtures of 
alginate/hyaluronic acid is shown in Figure 4.5. As is shown, 1.5% alginate behaves like 
Newtonian fluid, where the shear stress is directly proportional to the shear rate. It has a constant 
viscosity of 41 cp. Mixtures of alginate with hyaluronic acid instead behave like the non-
Newtonian fluid, with the flow behavior index being less than one (Table 4.2). The mixtures has 
the viscosity decreasing with increasing shear rate (shear thinning), which is illustrated in Figure 
4.6. Table 4.2 summarizes the different parameters (named flow behavior parameters) for the 
generalized power law mentioned in section 4.2.2 for each mixture. The flow behavior 
measurement results showed that the flow behavior parameters, particularly the yield stress and 
consistency index varied with the concentration of hyaluronic acid. Mixtures with higher 
concentration of hyaluronic acid had bigger yield stress and higher consistency index, but lower 
flow index. As yield stress of the biomaterials for the scaffold fabrication needs to be high to 
maintain the 3D interconnected microstructures, the addition of hyaluronic acid into 1.5% 
alginate solution makes the mixtures a more feasible biomaterial for 3D scaffold fabrication 
using the dispensing-based rapid prototyping system [134].   
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Table 4.2 Flow Behavior Parameters for Four Alginate/Hyaluronic Acid Mixtures  
Mixtures  τ
0 
(D/cm)  K (cp)  n  
1.5% Alginate/0%  
Hyaluronic Acid 
-11.38  100.2  0.87  
1.5% Alginate/0.375% Hyaluronic 
Acid  
20.30  1719.0  0.60  
1.5% Alginate/0.50% Hyaluronic Acid  37.20  2835.0  0.56  
1.5% Alginate/0.75% Hyaluronic Acid  113.6  6151.0  0.49  
 
Viscosity-shear rate curves of alginate/hyaluronic acid mixtures in Figure 4.6 showed that 
the viscosity of mixtures increased with the increased amount of hyaluronic acid at low strain 
rates, while the difference was not significant at high strain rates. 
Figure 4.5 Shear stress vs. shear rate curves of alginate/hyaluronic acid mixtures at 
different shear rates. 1.5% alginate behaved like Newtonian fluid while the 
alginate/hyaluronic acid mixtures behaved like non-Newtonian fluid. With the increase of 
the concentration of hyaluronic acid, yield stress of the mixture increased. 
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4.3.2 Scaffold Fabrication 
Scaffold fabrication was carried out based on the model of the strut diameter. Volume 
flow rate with predefined needle geometry and nozzle disposition velocity was calculated 
according to Eq. (4.3). The adapted fluid dispensing machine has the function to measure the 
mass flow rate. Thus, the air pressure can be adjusted to get the required flow rate. Different 
dispensing velocities were tested to investigate the effectiveness of proposed fabrication 
technique and to examine the effect of nozzle deposition velocity on the strut structure. From 
Figure 4.7, we can see the orthogonal pore structure for scaffolds dispensed at velocities of 5 
mm/s and 10 mm/s. Strands of the first layer had a larger diameter compared to those of the 
second layer, probably because of the surface tension and contact angle. Higher velocities of 15 
Figure 4.6 Viscosity vs. shear rate curves of alginate/hyaluronic acid mixtures. 
Alginate/hyaluronic acid mixtures behaved like non-Newtonian fluid, with the viscosity 
decreasing with increasing shear rate. The viscosity of mixtures increased with the 
increased amount of hyaluronic acid. 1.5% alginate solution behaved like Newtonian fluid 
and had a constant viscosity of 41 cp. 
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mm/s and 20 mm/s led to the non-linear strand profile of scaffolds. As indicated by the first 
layers which had uniform and linear strand profile, the dispensing parameters such as dispensing 
velocity, needle size, and air pressure were suitable for the fabrication process of 1.5% 
alginate/0.75% hyaluronic acid mixture. Thus, the irregular shaped 2D scaffolds dispensed at 15 
mm/s and 20 mm/s may be due to the mechanical vibration of the dispensing system, initial 
needle height or crosslinker solution level. 
 
Effect of initial needle height on the strut diameter and linearity was then investigated 
and the result shown in Figure 4.8 indicated that strand formation was highly dependent on the 
initial needle height. For the mixture of 1.5% alginate/0.75% hyaluronic acid and the dispensing 
parameters of nozzle deposition velocity at 10 mm/s, mass flow rate at 0.52 mg/s, and needle 
Figure 4.7 Images of 1.5% alginate/0.75% hyaluronic acid scaffolds dispensed at different 
velocities and correspondent mass flow rates (a) 5 mm/s, 0.26 mg/s (b) 10 mm/s, 0.52 mg/s 
(c) 15 mm/s, 0.76 mg/s, and (d) 20 mm/s, 1.00 mg/s. Scale bars: a, b, c, d=1 mm. 
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size of 250 , an initial needle height of 0.35 mm results in linear strands (Figure 4.8 (a)) while 
higher needle heights of 0.40 mm, 0.45 mm, 0.55 mm led to curved strand structures as shown in 
Figure 4.8 (b), (c), and (d). Figure 4.8 (e) and (f) revealed the even less uniform shape of the 
dispensed strands with further increase of the initial needle height. 
 
Figure 4.8 Initial needle heights of (a) 0.35 mm, (b) 0.40 mm, (c) 0.45 mm, (d) 0.55 mm, (e) 
0.60 mm, and (f) 0.65 mm tested to assess the effect of initial needle height on the strut 
diameter and linearity. Scale bars: a, b, c, d=1 mm. 
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Possible explanation for the effect of initial needle height on the strand profile is that the 
dispensed fluid didn’t touch the Petri dish bottom until enough liquid was accumulated for the 
gravity force to overcome the surface tension. Thus, the actual velocity of deposit ion was smaller 
than the calculated value, which was supposed to match the correspondent flow rate. Along with 
this, the strand had a shorter length and a bigger diameter with a higher initial needle height 
compared to a lower initial needle height. 
Crosslinking of alginate/hyaluronic acid mixtures by CaCl2 is dependent on the CaCl2 
concentration, which may in turn affect the strut diameter and attachment between layers. High 
CaCl2 concentration leads to extensive crosslinking of alginate and shrinkage of strut diameter. 
On the other hand, gelation speed of the dispensed strut increases with the CaCl2 concentration, 
which might result in the detachment of different layers. Thus, it is important to study the effect 
of CaCl2 concentration on the geometrical formation of 3D scaffolds. Figure 4.9 showed the strut 
diameters of 1.5% alginate/0.375% hyaluronic acid mixture dispensed into CaCl2 solution with 
different concentrations. As observed, all concentrations led to a bigger strut diameter than 250 
µm. This may be due to the swelling of the uncrosslinked hyaluronic acid in the strut after one 
day. And there was significant difference in strut diameter between 10 mM and the rest 
concentrations, P < 0.0001. Though higher concentration of CaCl2 seemed to result in a smaller 
strut diameter, the difference was not significant.  
In terms of connectivity between layers, 50 mM or 75 mM CaCl2 is preferable for 1.5% 
alginate/0.375% hyaluronic acid. Five samples of 4-layered scaffolds were fabricated for each 
concentration and immersed in correspondent CaCl2 solution for one day, after which the 
integrity of the scaffolds were examined visually. The result showed that concentrations of 10 
mM, 50 mM and 75 mM maintained the integrity of the fabricated scaffolds. Group of 100 mM 
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CaCl2 had two scaffolds falling apart and three intact. And higher concentration of 150 mM had 
all the scaffolds lose their structure. For the mixture of 1.5% alginate/0.5% hyaluronic acid, 100 
mM of CaCl2 was found to be more favorable in terms of strut diameter and connectivity. 
 
Concentration of CaCl2 has an effect on the strut diameter and the connectivity between 
different layers of the scaffolds. High concentration of CaCl2 leads to more ionic crosslinking of 
alginate, which would result in the shrinkage of dispensed struts. As for the connectivity, it is 
likely that the presence of hyaluronic acid would hinder the crosslinking of alginate with CaCl2, 
thus the problem of detachment between dispensed layers using the same concentration of CaCl2 
will become less severe for the mixture with higher concentration of hyaluronic acid compared to 
the one without or with lower concentration of hyaluronic acid. This, on the other hand, indicates 
that a higher concentration of CaCl2 might be more suitable for the alginate/hyaluronic acid 
mixture with higher concentration of hyaluronic acid. This helps to explain why higher 
concentration of CaCl2 (100 mM) is more appropriate for 1.5% alginate/0.5% hyaluronic acid 
Figure 4.9 Effect of CaCl2 concentrations on strut diameter of ionically-crosslinked 1.5% 
alginate/0.375% hyaluronic acid hydrogel scaffolds. Error bars represent the standard 
deviation; *** P < 0.0001. 
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while mixture of 1.5% alginate/0.375% hyaluronic acid requires 50 mM or 75 mM of CaCl2 to 
obtain the desired strut diameter and good attachment of different layers.  
Figure 4.10 shows two examples of the multilayer scaffolds fabricated using the adapted 
fluid dispensing system: (a) four-layer scaffold with the first two layers detached; (b) top view of 
a 10-layer scaffold. As we can see, while the 4 or 5 layer scaffolds can be fabricated with open 
pores, scaffolds with more layers is problematic with non-interconnected pores. 
 
Multilayer scaffolds fabricated from the 3D Bioplotter
TM
 system were shown in Figure 
4.11. As we can see, the strands were linear and uniform, with interconnected pore structures. 
This indicated the feasibility of fabricating 3D scaffolds with predefined and reproducible 
microstructure using the 3D Bioplotter
TM
 system.  
 
Figure 4.10 Examples of the multilayer 1.5% alginate/0.375% hyaluronic acid scaffolds 
fabricated by the adapted fluid dispensing system: (a) four-layer scaffold with the first two 
layers detached; and (b) top view of a 10-layer scaffold. Scale bars: a, b=1 mm. 
 
(a)                                                                             (b) 
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(a) 
(b) 
Figure 4.11 An example of the multilayer scaffolds fabricated using the 3D Bioplotter
TM
 
system. (a) 3D porous structure of 1.5% alginate/0.375% hyaluronic acid hydrogel 
scaffolds dispensed by SmoothFlow™ Tapered Tips with the inner diameter of 200 um, 
image taken at 25× magnification, scale bar=1 mm; (b) the same scaffold imaged at 50× 
magnification, scale bar=100 µm. 
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4.3.3 Mechanical Properties 
Bioengineered tissue scaffolds provide necessary mechanical support for the native tissue 
while the scaffold should not be too hard to damage the surrounding tissue. And compression is 
the most common form of spinal cord trauma. Thus, uniaxial compression test was carried out on 
the alginate/hyaluronic acid hydrogels to study their mechanical properties. Though the 3D 
porous scaffolds dispensed by the dispensing-based rapid prototyping system were aimed for the 
later in vitro and in vivo study of SCI repair in animal models, measurement on the cylindrical 
hydrogel samples would facilitate the fabrication process while providing important information 
about the mechanical properties of the hydrogels. The result indicated that the stress-strain 
curves of four samples from each group were not very consistent, probably due to the difficulty 
to accurately transfer the viscous mixtures into the molds, the non-uniform crosslinking density 
or the uneven surface of the hydrogels. These are the common issues involved with the 
mechanical test of hydrogels.  
Typical stress-strain curves for each group of hydrogels were shown in Figure 4.12. As 
shown in the figure, 1.5% alginate hydrogels with different amounts of hyaluronic acid added 
behaved like soft tissue, having stress-strain curves of an exponential shape. An initial linear 
region existed in each group with hyaluronic acid added. The elastic modulus or Young’s 
modulus for compression, one key parameter of the mechanical properties, is the slope of the 
linear region of the stress-strain curve. Elastic moduli of the different alginate/HA hydrogels 
were difficult to obtain as the elastic regions are hard to determine and stress-strain curves of 
each group varied quite a lot from sample to sample. However, the slope of the stress-strain 
curve at the strain of 0.03 was calculated for each sample and averaged to get the average elastic 
modulus for each alginate/HA hydrogel. And no significance was found in the elastic modulus 
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for compression between different groups, as shown in Figure 4.13. Stress of 1.5% alginate/0% 
HA hydrogels had a linear relationship with strain, demonstrating as an elastic material. After the 
point of the proportional limit, the hydrogels had the non-linear profile of the stress-strain curve, 
indicating the materials underwent plastic deformation. For this non-linear region, tangent 
modulus, the slope of the stress-strain curve at a certain strain, is used to characterize the 
mechanical properties of materials stressed beyond the yield point. Calculating the tangent 
moduli of different hydrogels at the same strain of 0.18, surprisingly, we can find that there was 
no significant difference in the tangent modulus between different hydrogels, as shown in Figure 
4.14. 
 
Figure 4.12 Stress-strain curves of cylindrical alginate/hyaluronic acid hydrogels 
measured at the strain rate of 0.0083/s. One typical stress-strain curve was selected from 
each group. The alginate/hyaluronic acid hydrogels behaved like soft tissue, having stress-
strains of an exponential shape while alginate hydrogels demonstrated as an elastic 
material with linear strain-strain curves. 
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Scaffolds’ mechanical test showed that the cylindrical hydrogels crosslinked by 50 mM 
CaCl2 for 24 hours demonstrated a viscoelastic compressive behavior as native spinal cord and 
Figure 4.13 Average elastic moduli of ionically-crosslinked hydrogels of 1.5% alginate 
with 0%, 0.375%, 0.5% and 0.75% hyaluronic acid. Elastic modulus represents the slope 
of the stress-strain curve at the proportional region. Error bars represent the standard 
deviation; P > 0.05. 
 
Figure 4.14 Average tangent moduli of four alginate/hyaluronic acid hydrogels at the 
strain of 0.18. Error bars represent the standard deviation and no significant difference 
was found between the different hydrogels based on the one-way ANOVA. 
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had tangent moduli of 70-80 KPa (measured at the strain rate of 0.0083/s). Also, there was no 
significant difference in the elastic modulus and tangent modulus between different hydrogels. 
There are many tension tests on both animal and human spinal cord, but not many compression 
studies have been done on the spinal cord samples. The reported mechanical properties for the 
spinal cord tissue are not consistent but usually within the range of 3 KPa to 300 KPa [72, 107, 
108, 142]. Stress-strain curves of porcine spinal cord white matter all have an exponential shape 
at different strain rates [143]. To achieve biomimetic mechanical properties of the spinal cord 
tissue, the concentration of CaCl2, and gelating time used for ionic crosslinking can be adjusted 
to meet a particular application.  
Also, it was found that elastic modulus of 2 KPa to 5 KPa is likely to be most favorable 
for neurite extension and neural differentiation of progenitors [144-146]. The elastic moduli of 
different hydrogels were around 5 KPa to 20 KPa and had no significant difference between 
different groups. This indicated that the CaCl2-crosslinked hydrogels of 1.5% alginate with 
different amounts of HA had quite suitable mechanical properties for neurite outgrowth and 
neural differentiation. And the composite biomaterial with adjustable mechanical properties (by 
changing the CaCl2 concentration) could be applied to culture the neuron stem cells for cell 
differentiation and proliferation studies.   
 
4.4 Conclusions 
This chapter presents the fabrication of 3D scaffolds of CaCl2 crosslinked 1.5% alginate 
with different concentrations of hyaluronic acid using the dispensing-based rapid prototyping 
systems, both the adapted fluid dispensing system and the 3D Bioplotter
TM
. Flow behavior of the 
different mixtures was characterized to facilitate the fabrication process. And the results showed 
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that 3D construct cannot be produced from ionically-crosslinked 1.5% alginate, due to the low 
yield stress necessary for 3D configuration. And 3D scaffolds can be fabricated from CaCl2 
crosslinked 1.5% alginate with 0.375%, 0.5% and 0.75% hyaluronic acid. Due to the 
unsatisfying resolution and difficulty to adjust the air pressure to exact value of the adapted fluid 
dispensing system, fabricated scaffolds aren’t quite reproducible. This also makes the 
interpretation of experiment results challenging. Application of more sophisticated rapid 
prototyping fabrication systems such as 3D Bioplotter
TM
 to repeat this part of work would 
extensively make this piece of work more worthwhile. And the fabricated 3D scaffolds using the 
3D Bioplotter
TM
 system also indicated its superiority in producing scaffolds with controllable 
and reproducible microstructure over the adapted fluid dispensing machine.   
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CHAPTER 5 General Discussions 
5.1 Summary and Conclusions 
In this study, composite biomaterial made from alginate and hyaluronic acid was 
synthesized and characterized by the FTIR spectrum to confirm the covalent crosslinking in 
Chapter 2. Alginate’s instant gelation with CaCl2 was employed to make use of its ease to 
construct 3D structure by the dispensing process while incorporation of hyaluronic acid may 
provide cellular and molecular interaction with native tissue to improve SCI repair outcome. 
Covalent crosslinking of hyaluronic acid and alginate with ADH mediated by EDC under an 
acidic condition may postpone the in vivo residence time, which is typically several months for 
SCI repair. The loss of mechanical strength of alginate hydrogels with 15 hours after in vivo 
transplantation could be overcome by the covalently-crosslinked hyaluronic acid and alginate. 
The FTIR measurements showed that there was covalent modification with the crosslinking 
protocol described in Chapter 2. The covalent modification was found to be dependent on the 
concentrations of EDC and CaCl2, as well as the pH value of the reaction. 
In Chapter 3, the biocompatibility of the composite hydrogels for Schwann cells, which 
are proven to play a key role in the spinal cord regeneration, was investigated. For this, 
substrates double-crosslinked for both 6 hours and 20 hours were examined for Schwann cell 
viability and growth. The results indicated that cells survived on the double-crosslinked 
alginate/hyaluronic acid hydrogels, despite that there were not as many cells as the tissue culture 
plate. Also, there was no significant difference between different substrates prepared from 
different volume ratios of 3% alginate and 0.75% hyaluronic acid. Treated with PLL coating, the 
20%-80% alginate/hyaluronic acid hydrogels showed improved Schwann cell adhesion and had 
more cells growing compared to the non-treated group. However, cells remained circular without 
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extended processes, indicating the lack of adhesive property of the hydrogels for Schwann cells. 
Additionally, covalent crosslinking by EDC mediated amide formation and high concentration of 
hyaluronic acid seemed to be inhibitory for Schwann cell survival and growth, resulting in fewer 
cells when compared to the controls. Hydrogels of ionically-crosslinked 1.5% alginate/0.375% 
hyaluronic acid or 1.5% alginate/0.5% hyaluronic acid may be most suitable for Schwann cell 
culture. 
In Chapter 4, 3D scaffold fabrication by the dispensing-based rapid prototyping systems 
was investigated. The result indicated the feasibility to fabricate 3D alginate/hyaluronic acid 
tissue construct with controllable microstructure using the dispensing-based rapid prototyping 
systems. The influence of flow behavior, initial needle height and CaCl2 concentration for the 
formality of scaffolds was examined. The result showed that 3D scaffolds can be fabricated from 
mixtures of 1.5% alginate with hyaluronic acid but not 1.5% alginate alone. The initial height of 
the dispensing needle tip from the surface of CaCl2 solution imposed a significant effect on the 
formality of scaffolds. Concentration of CaCl2 solution had an impact on the strand profile with 
50 mM or 75 mM preferable for 1.5% alginate/0.375% hyaluronic acid and 100 mM for 1.5% 
alginate/0.5% hyaluronic acid in terms of strand diameter and attachment between layers.   
Scaffolds’ mechanical test showed that the cylindrical hydrogels crosslinked by 50 mM 
CaCl2 for 24 hours demonstrated a viscoelastic compressive behavior as native spinal cord and 
had tangent moduli of 70-80 KPa (measured at the strain rate of 0.083mm/s). Also, there was no 
significant difference in the tangent modulus between different hydrogels. Two fabrication 
methods were tried on the adapted commercial fluid dispensing system and the 3D Bioplotter
TM
 
respectively and both methods were successful in fabricating multilayer scaffolds. However, in 
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terms of the ease to fabricate 3D scaffolds, the method to dispense first two layer patterns onto 
the tissue culture plate without the presence of CaCl2 is more controllable and repetitive.  
 
5.2 Discussions 
This is the first study of synthesis, characterization and fabrication of alginate/hyaluronic 
acid composite hydrogels for the application of SCI repair. Alginate was incorporated into the 
hyaluronic acid in this study so as to enhance the feasibility to fabricate 3D scaffold from the 
composite biomaterial. Fast gelation of alginate with CaCl2 provides the mechanical strength of 
dispensed strands. Without alginate, hyaluronic acid could not form scaffolds with open pores 
even if the covalent crosslinking of hyaluronic acid with ADH by EDC was applied. This is 
because the covalent modification is not quick enough to solidify the dispensed strands. 
 The concentration of alginate was set at 1.5% as 1.5% alginate was high enough to be 
crosslinked by CaCl2 to provide sufficient mechanical support in the dispensing process. Higher 
concentrations of the alginate are unwanted as alginate has been shown to be not favorable for 
Schwann cell adhesion with cells demonstrating spherical shape. It also inhibits the Schwann cell 
metabolic activity and neurite outgrowth of the DRG neurons [46]. Addition of fibronectin 
increased the DRG neurite outgrowth but cannot change the spherical morphology of Schwann 
cells [46]. Thus, it is unnecessary that the alginate/hyaluronic acid hydrogels will not permit 
DRG neurite outgrowth even though the morphology of the cultured Schwann cells on the 
composite biomaterial indicated that the hydrogels were not suitable for Schwann cell attachment. 
Culture of DRG neurons on or within the alginate/hyaluronic acid composite hydrogels will 
shred a light on this. 
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Also in vivo transplantation of the alginate/hyaluronic acid hydrogels should be done 
even when the primary in vitro study of the composite biomaterial in promoting neurite 
outgrowth of DRG neurons is not encouraging. This is due to the fact that cell culture on the 2D 
scaffold or within 3D scaffold in vitro differs from the in vivo study with the transplanted 
scaffolds. The underlying mechanisms are complex and not well understood. It is likely that the 
composite biomaterial of alginate and hyaluronic acid might result in an advantageous effect in 
promoting axonal regeneration though the outcome of DRG culture may be quite negative.  
Hyaluronic acid is not adhesive for cell attachment both in vitro and in vivo. The non-
adhesive property of hyaluronic acid limits the attachment of Schwann cells and DRG neurons. 
Thus, it is likely that the composite hydrogels may restrain the neurite outgrowth of DRG 
neurons in vitro. And it is interesting to find out that there was extensive neurite outgrowth of a 
single DRG neuron in the crosslinked thiol-modified hyaluronic acid-poly (ethylene glycol)-
diacrylate though there was no significant improvement of motor evoked potentials, retrograde 
axonal labeling or behavioral assessment in vivo in a complete thoracic spinal cord transection 
rat model [77]. 
Application of hyaluronic acid to the SCI lesion site results in significant decrease in scar 
formation and astrocytic response; it is necessary to maintain the excellent biological benefits 
provided by the hyaluronic acid when modification of hyaluronic acid is made for better SCI 
regeneration. Application of soluble high molecular weight hyaluronic acid in vitro decreased 
astrocyte activation and proliferation and the deposition of inhibitory chondroitin sulfate 
proteoglycans. The implantation of the crosslinked hyaluronic acid hydrogels with the 
biomimetic mechanical strength in a rat model of spinal dorsal hemisection injury also showed 
significant decrease of immune cells, chondroitin sulfate proteoglycans production, and astrocyte 
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response [147]. It was suggested that the interaction of high molecular hyaluronic acid with the 
CD 44 receptor on cell membrane accounted for the inhibitory effect of hyaluronic acid on scar 
formation after SCI [148, 149]. Y.T. Wei et al. had implanted the freeze-dried hyaluronic acid 
hydrogels modified with nogo-66 antibody and PLL in a rat model of lateral hemisection of 
spinal cord and they found that the hydrogels resulted in angiogenesis, reduction of glial scar, 
and axons growing into the hydrogels [76]. With the encouraging results of these studies, it is 
likely that the interconnected microstructure offered by the rapid prototyped alginate/hyaluronic 
acid scaffolds in this study might further increase the possibility of alginate/hyaluronic acid 
composite hydrogels to promote axonal regeneration.  
 In this study, the feasibility of alginate/hyaluronic acid composite biomaterial for 3D 
scaffolds for the applications in SCI repair was studied from the aspects of chemistry, 
biocompatibility, and feasibility of 3D scaffold fabrication. And the result of chemical 
characterization showed that there was covalent crosslinking of the alginate/hyaluronic acid 
composite substrates by EDC with ADH, even in the presence of CaCl2.  
EDC mediated amide formation has been widely used in tissue engineering to modify the 
biomaterial, either to couple one material to another, or to incorporate bio-functional 
biomolecules such as cell adhesion peptides into the biomaterial [150]. The reaction is highly 
dependent on the pH value and the optimal pH for the two steps of reaction is different. On one 
hand, carboxylic acid activation by EDC is most efficient in an acidic environment with pH 
value of 3.5-4.5 [79]. Meanwhile, amide formation is suggested to be best done at high pH value 
when the amine is deprotonated. At high pH, EDC can rapidly hydrolyze into the N-acylurea by-
product and no amidation may occur. Thus, amines with high pKa are not easily conjugated to 
the polymer by EDC. Replacing diamines by dihydrazides, such as ADH, which have much 
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lower pKa values of 2-3, increase the coupling efficiency to up to 56% [151]. However, 
excessive ADH added will only lead to single functionalization of hyaluronic acid, which doesn’t 
result in the crosslinked hyaluronic acid. In this study, the physical change of the hyaluronic acid 
or alginate solution into hydrogels with mechanical strength indicated that the covalent 
crosslinking of the polymers did occur.  
The reaction efficiency of EDC mediated amide formation of alginate/hyaluronic acid 
with ADH was not measured in this study. This could be measured through the radio-labeled 
ADH. In this way, the amide formation of hyaluronic acid, alginate and alginate/hyaluronic acid 
with ADH will be quantitatively confirmed. It can also help to determine the carboxylate groups 
responsible for the covalent modification of alginate. If the alginate in alginate/hyaluronic acid 
mixture can be further crosslinked with ADH by EDC as the alginate solution itself, this would 
help to reduce the biodegradation rate of alginate/hyaluronic acid hydrogels in vitro and in vivo 
and may affect the mechanical and swelling properties of the hydrogels. As discussed in Chapter 
1 about EDC crosslinking, the side reaction of EDC with carboxyl groups to form N-acylurea 
may affect on the amide formation of carboxyl groups of the polymer with ADH to crosslink the 
alginate/hyaluronic acid. Thus, measurement of conjugation efficiency will help to determine the 
proper EDC concentration, ADH amount, CaCl2 concentration and pH value for the covalent 
crosslinking. Thus, quantitative measurement of the amide formation is essential.   
The biocompatibility of alginate/hyaluronic acid hydrogels for viability and growth of 
Schwann cells was identified in this study. Primary examination of the Schwann cell growth on 
the double-crosslinked alginate/hyaluronic acid hydrogels on 2
st
, 3
nd
 and 5
th
 day demonstrated 
that Schwann cells survived and grew on the substrates, indicating that the hydrogels were 
permissive for Schwann cell growth. No significant difference was found in the double-
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crosslinked alginate/hyaluronic acid hydrogels with various concentrations of alginate and 
hyaluronic acid. This probably is attributable to the lack of HA’s mediation on cell proliferation. 
Schwann cells express CD44, a major HA binding protein that mediates various cellular 
processes including cell-cell adhesion, migration and differentiation [152, 153]. However, HA 
may not affect the Schwann cell survival and proliferation though high molecular weight HA was 
found to inhibit the proliferation of astrocytes. Findings of Suri S and Schmidt C E also 
illustrated this when incorporation of HA into collagen did not change the Schwann cell viability 
and proliferation [154]. Studies need to be carried out to confirm this. One another explanation is 
that the variance of the HA concentration was not large enough to affect on the cell number of 
Schwann cells. The maximal concentration of HA was 0.75%, as higher concentrations of HA 
were too viscous to handle and would be difficult for the fabrication process.  
Treatment of PLL coating on the double-crosslinked alginate/hyaluronic acid hydrogels 
increased the adhesion and cell number of Schwann cells. PLL is positively charged and through 
the electrostatic interaction between negatively charged ions of the cell membrane of Schwann 
cells and the culture surface (alginate/hyaluronic acid hydrogels), the adhesion of Schwann cells 
could be increased. However, here the PLL itself is not sufficient to overcome the non-adhesive 
property of alginate/hyaluronic acid hydrogels. Studies using hyaluronic acid hydrogels 
covalently modified by PLL on the hippocampus neuron culture also demonstrated the lack of 
cell spreading and attachment [76]. Modified with both PLL and Nogo-66 receptor antibody, 
neurons exhibited multipolar or bipolar morphology [76]. This indicated the necessity to 
carefully modify the alginate/hyaluronic acid hydrogels so as to promote the adhesion of 
Schwann cells and neurons as well as the neurite outgrowth both in vitro and in vivo.  
Modification of alginate or hyaluronic acid hydrogels to permit cell adhesion and neurite 
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outgrowth has been successfully achieved by either incorporating other natural ECM component 
(e.g., laminin, collagen) or cell adhesive polypeptides (laminin peptides) [96, 100, 150, 155-158]. 
It remains to be determined what functionalization method, protein/peptide species and 
concentration are most effective and efficient for the alginate/hyaluronic acid composite 
hydrogels. 
Number of Schwann cells on the ionically crosslinked 1.5% alginate/0.375%, 0.5% and 
0.75% hyaluronic acid hydrogels have a significant difference from those of the double-
crosslinked ones. The loss of uncrosslinked hyaluronic acid in the ionically crosslinked 
alginate/hyaluronic acid hydrogels into the culture media may reduce the inhibitory effect of 
hyaluronic acid on the cell proliferation. EDC was applied as the enzyme to activate the chemical 
reaction as it is thought to be the “green crosslinker”, having better biocompatibility with the 
product transferred into urea. However, there has been research indicating the toxicity of EDC-
mediated amide formation. The acid condition required by the reaction is also an issue. Non-
reacted EDC crosslinker may be also toxic to the cells, leading to the low cell number in the 
double-crosslinked alginate/hyaluronic acid hydrogels.  
In addition, mechanical properties of the double-crosslinked hydrogels are likely to differ 
from the ionically crosslinked ones, leading to decreased cellular activities as studies have 
indicated that the mechanical properties of substrates can modulate such cellular activities as 
attachment, differentiation, and proliferation [72, 159-161]. In general, scaffolds with most 
biomimetic mechanical properties as the ECM environment of particular cells will result in most 
cell differentiation, and proliferation and migration. For Schwann cells and neurons, soft 
scaffolds support more cell proliferation. Therefore, the fewer cells growing on the double-
crosslinked alginate/hyaluronic acid hydrogels may indicate the stronger mechanical properties 
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of hydrogels caused by the double crosslinking. Mechanical tests on the double-crosslinked 
hydrogels and the ionically crosslinked ones as described in Chapter 4 would provide insights 
into this.  
3D scaffold fabrication of 1.5% alginate/0.375%, 0.5% and 0.75% hyaluronic acid 
hydrogels were successfully achieved and the effect of initial needle height, concentration of 
CaCl2 and fluid behavior on the formation of 3D scaffolds was evaluated. The method of 
dispensing alginate/hyaluronic acid mixture into CaCl2 crosslinker solution involved the problem 
of surface tension, which made the fabrication process hard to control. Surface tension refers to 
the property of the surface of a liquid that allows it to resist an external force. It causes the 
floating of the dispensed strands on the surface of the CaCl2 solution, in spite of the higher 
density of alginate/hyaluronic acid mixtures. The surface tension then causes the liquid surface to 
contract to the minimal area. The dispensed strands were then contracted by the tension force, 
leading to the non-uniform strand structure. Also, the stream of alginate/hyaluronic acid mixture 
tends to adhere to the dispensing needle tip until the point where the gravity overcomes the 
surface tension to stretch the stream to fall. Mixtures assemble into spherical drops rather than 
streams. This makes the fabrication of alginate/hyaluronic acid scaffolds difficulty.  
The effect of initial needle height on the formation of strands illustrated in Chapter 4 is 
attributed to the surface tension and can be minimized by setting the distance of the needle tip 
from the surface of the Petri dish to a value that allows the dispensed strand to form the bridge 
between the needle tip and the Petri dish surface [162]. Once the effect of surface tension is 
excluded, the fabrication process could be facilitated by the model of strut diameter and mass 
flow rate measurement. With predefined nozzle geometry and nozzle deposition velocity, the 
volume flow rate needed for strand diameter equal to the nozzle diameter can be obtained. The 
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air pressure required will be then determined through the measurement of mass flow rate.  
There was no significant difference in strand diameter at different concentrations of 
CaCl2 solution except the group of 10 mM CaCl2. Concentration of 50 mM to 150 mM led to 
extensive ionic gelation of alginate with calcium cations. High concentration of CaCl2 leads to 
the shrinkage of the dispense strands. However, this effect is probably overcome by the swelling 
of alginate/hyaluronic acid hydrogels. The detachment of different layers is an issue occurring in 
the fabrication process when the alginate/hyaluronic acid mixture is dispensed into the CaCl2 
solution. To eliminate this problem, the dispensing process should be instant, with little time 
interval between different layers. Also, the volume of the CaCl2 solution should be controlled to 
just cover the dispensed layers. Still, the CaCl2 concentration should not be too high. One 
another method is to incorporate EDTA and/or citric acid to lower the speed of ionic crosslinking. 
Affected by the competitive sequestering of calcium ions by the EDTA and/or citric acid, the 
gelation of alginate with CaCl2 could be decreased.  
Fabrication of 3D alginate/hyaluronic acid scaffolds by the 3D Bioplotter
TM
 is a little bit 
different from the way using the adapted commercial fluid dispensing system. With the precise 
control of air pressure and displacement, fabrication of strands with desired diameter is quite 
easy, making the mass flow rate measurement useless. Directly dispensing the material onto the 
Petri dish surface avoids the problem of surface tension caused by the CaCl2 solution. Removal 
of the excess CaCl2 solution every two layers after crosslinking was also done to eliminate the 
effect of surface tension. The initial needle height from the Petri dish can be set at a value equal 
to 80% of the strand diameter and was heightened by the same value layer by layer. 80% instead 
of 100% of the desired strand diameter was used to ensure the well attachment of different layers. 
The problem of this method is that there is probably fusion at the contact region of the newly 
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dispensed layer and the previously dispensed layer as illustrated in Figure 4.11. The newly 
dispensed strands may yield and spread before the application of crosslinker solution. Mixtures 
of 1.5% alginate with 0.5% hyaluronic acid or 0.75% hyaluronic acid have larger yield stresses 
and thus are less likely to yield and spread while solution of 1.5% alginate is not viscous enough 
to maintain its structure. In term of this, incorporation of hyaluronic acid into 1.5% alginate 
facilitates the fabrication process.  
 
5.3 Recommendations for Future Work 
In this study, the double-crosslinked alginate/hyaluronic acid hydrogels were synthesized 
and characterized by the FTIR spectrum. The amide formation were examined, but the amount of 
covalent modification and the responsible carboxyl groups in the composite hydrogels for 
covalent modification need to be further investigated through the quantitative measurement of 
amide formation. Characterization of the synthesized composite hydrogels from the aspects of 
swelling rate measurement, in vitro and in vivo biodegradation study should be carried out to 
better understand the properties of the composite material. Effects of crosslinker solutions, ADH 
concentration and gelation time on the properties of the composite material should also be well 
studied to tailor the biomaterial for a particular application.  
Biocompatibility study of the composite biomaterial, either ionically crosslinked or 
double-crosslinked ones, was carried in this work using the in vitro Schwann cell culture. As 
discussed in the section of discussions, though the biomaterial allowed for the Schwann cell 
viability and growth, the substrates were not well suited for cell attachment. Modification of the 
non-adhesive property of the alginate/hyaluronic acid hydrogels to promote cell attachment and 
neurite outgrowth needs to be investigated. The reason for the decreased cell number on the 
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double-crosslinked alginate/hyaluronic acid hydrogels compared to the ionically crosslinked 
alginate/hyaluronic acid hydrogels is unknown and requires further investigation.  
Fabrication of 3D scaffolds from the ionically crosslinked alginate/hyaluronic acid 
hydrogels was tried and the mechanical properties of the cylindrical hydrogels were evaluated. 
Work done on the adapted fluid dispensing system should be repeated on the 3D Bioplotter
TM
 
system, with its higher resolution provided, to better understand the results. Future work looking 
into mechanical properties of the double-crosslinked cylindrical hydrogels and the dispensed 3D 
porous scaffolds as well as the effects of gelation time, crosslinker concentration, strain rate, and 
microstructure on the mechanical properties of scaffolds needs to be done.  
Lastly, in vitro and in vivo study of the fabricated 3D porous scaffolds using the DRG 
culture and a rat model of SCI will finally show the promise of this composite biomaterial for 
axonal regeneration and functional recovery of traumatic spinal cord. Integrated with other 
therapeutic strategies such as incorporation of bioactive molecules, living cells and electrical 
stimulation, the rapid prototyped alginate/hyaluronic acid scaffolds may turn out to be a 
promising option for SCI repair.  
 93 
 
LIST OF REFERENCES 
1. NSCISC. Spinal cord injury facts and figures at a glance 2011; Available from: 
www.nscisc.uab.edu/public_content/facts_figures_2009.aspx. 
2. Blumenfeld H. Neuroanatomy through clinical cases. Sunderland, Sinauer Associates, 
2002. 
3. Fawcett JW, Asher RA. The glial scar and central nervous system repair. Brain Res Bull 
49(6): 377-91, 1999. 
4. George R, Griffin JW. Delayed macrophage responses and myelin clearance during 
Wallerian degeneration in the central nervous system: the dorsal radiculotomy model. 
Exp Neurol 129(2): 225-36, 1994. 
5. Buss A, Schwab ME. Sequential loss of myelin proteins during Wallerian degeneration in 
the rat spinal cord. Glia 42(4): 424-32, 2003. 
6. Ridet JL, Malhotra SK, Privat A, Gage FH. Reactive astrocytes: cellular and molecular 
cues to biological function. Trends Neurosci 20(12): 570-7, 1997. 
7. Schnell L, Schwab ME. Axonal regeneration in the rat spinal cord produced by an 
antibody against myelin-associated neurite growth inhibitors. Nature 343(6255): 269-72, 
1990. 
8. Fawcett JW. Intrinsic neuronal determinants of regeneration. Trends Neurosci 15(1): 5-8, 
1992. 
9. van Blitterswijk C HJ, Cancedda R, de Bruijn JD, Lindahl A, Sohier J, Williams D. 
Tissue Engineering. London, Academic Press, 2008. 
10. Neumann S, Bradke F, Tessier-Lavigne M, Basbaum AI. Regeneration of sensory axons 
within the injured spinal cord induced by intraganglionic cAMP elevation. Neuron 34(6): 
885-93, 2002. 
11. Neumann S, Woolf CJ. Regeneration of dorsal column fibers into and beyond the lesion 
site following adult spinal cord injury. Neuron 23(1): 83-91, 1999. 
12. Imaizumi T, Lankford KL, Waxman SG, Greer CA, Kocsis JD. Transplanted olfactory 
ensheathing cells remyelinate and enhance axonal conduction in the demyelinated dorsal 
columns of the rat spinal cord. Journal of Neuroscience 18(16): 6176-6185, 1998. 
13. De Laporte L, Shea LD. Matrices and scaffolds for DNA delivery in tissue engineering. 
Adv Drug Deliv Rev 59(4-5): 292-307, 2007. 
14. Chvatal SA, Kim YT, Bratt-Leal AM, Lee H, Bellamkonda RV. Spatial distribution and 
acute anti-inflammatory effects of Methylprednisolone after sustained local delivery to 
the contused spinal cord. Biomaterials 29(12): 1967-75, 2008. 
15. Lishko VK, Novokhatny VV, Yakubenko VP, Skomorovska-Prokvolit HV, Ugarova TP. 
Characterization of plasminogen as an adhesive ligand for integrins alpha(M)beta(2) 
(Mac-1) and alpha(5)beta(1) (VLA-75). Blood 104(3): 719-726, 2004. 
16. Zhang M, Yannas IV. Peripheral nerve regeneration. Adv Biochem Eng Biotechnol 94: 
67-89, 2005. 
17. Lu P, Jones LL, Tuszynski MH. BDNF-expressing marrow stromal cells support 
extensive axonal growth at sites of spinal cord injury. Exp Neurol 191(2): 344-60, 2005. 
18. Kamei N, Tanaka N, Oishi Y, Hamasaki T, Nakanishi K, Sakai N, Ochi M. BDNF, NT-3, 
and NGF released from transplanted neural progenitor cells promote corticospinal axon 
growth in organotypic cocultures. Spine (Phila Pa 1976) 32(12): 1272-8, 2007. 
 94 
 
19. Grill R, Murai K, Blesch A, Gage FH, Tuszynski MH. Cellular delivery of neurotrophin-
3 promotes corticospinal axonal growth and partial functional recovery after spinal cord 
injury. J Neurosci 17(14): 5560-72, 1997. 
20. Chen J, Wu J, Apostolova I, Skup M, Irintchev A, Kugler S, Schachner M. Adeno-
associated virus-mediated L1 expression promotes functional recovery after spinal cord 
injury. Brain 130(Pt 4): 954-69, 2007. 
21. Inoue M, Honmou O, Oka S, Houkin K, Hashi K, Kocsis JD. Comparative analysis of 
remyelinating potential of focal and intravenous administration of autologous bone 
marrow cells into the rat demyelinated spinal cord. Glia 44(2): 111-8, 2003. 
22. Papastefanaki F, Chen J, Lavdas AA, Thomaidou D, Schachner M, Matsas R. Grafts of 
Schwann cells engineered to express PSA-NCAM promote functional recovery after 
spinal cord injury. Brain 130(Pt 8): 2159-74, 2007. 
23. Lesny P, Pradny M, Jendelova P, Michalek J, Vacik J, Sykova E. Macroporous hydrogels 
based on 2-hydroxyethyl methacrylate. Part 4: growth of rat bone marrow stromal cells in 
three-dimensional hydrogels with positive and negative surface charges and in 
polyelectrolyte complexes. J Mater Sci Mater Med 17(9): 829-33, 2006. 
24. Hejcl A, Urdzikova L, Sedy J, Lesny P, Pradny M, Michalek J, Burian M, Hajek M, 
Zamecnik J, Jendelova P, Sykova E. Acute and delayed implantation of positively 
charged 2-hydroxyethyl methacrylate scaffolds in spinal cord injury in the rat. J 
Neurosurg Spine 8(1): 67-73, 2008. 
25. Hill CE, Moon LD, Wood PM, Bunge MB. Labeled Schwann cell transplantation: cell 
loss, host Schwann cell replacement, and strategies to enhance survival. Glia 53(3): 338-
43, 2006. 
26. Coumans JV, Lin TT, Dai HN, MacArthur L, McAtee M, Nash C, Bregman BS. Axonal 
regeneration and functional recovery after complete spinal cord transection in rats by 
delayed treatment with transplants and neurotrophins. J Neurosci 21(23): 9334-44, 2001. 
27. Maier IC, Ichiyama RM, Courtine G, Schnell L, Lavrov I, Edgerton VR, Schwab ME. 
Differential effects of anti-Nogo-A antibody treatment and treadmill training in rats with 
incomplete spinal cord injury. Brain 132(Pt 6): 1426-40, 2009. 
28. Qiu J, Cafferty WB, McMahon SB, Thompson SW. Conditioning injury-induced spinal 
axon regeneration requires signal transducer and activator of transcription 3 activation. J 
Neurosci 25(7): 1645-53, 2005. 
29. Orive G, Anitua E, Pedraz JL, Emerich DF. Biomaterials for promoting brain protection, 
repair and regeneration. Nat Rev Neurosci 10(9): 682-92, 2009. 
30. Zawko SA, Schmidt CE. Crystal templating dendritic pore networks and fibrillar 
microstructure into hydrogels. Acta Biomater 6(7): 2415-21, 2010. 
31. Duncan ID, Aguayo AJ, Bunge RP, Wood PM. Transplantation of rat Schwann cells 
grown in tissue culture into the mouse spinal cord. J Neurol Sci 49(2): 241-52, 1981. 
32. Oudega M, Xu XM. Schwann cell transplantation for repair of the adult spinal cord. J 
Neurotrauma 23(3-4): 453-67, 2006. 
33. Goto E, Mukozawa M, Mori H, Hara M. A rolled sheet of collagen gel with cultured 
Schwann cells: model of nerve conduit to enhance neurite growth. J Biosci Bioeng 109(5): 
512-8, 2010. 
34. Deng LX, Hu J, Liu N, Wang X, Smith GM, Wen X, Xu XM. GDNF modifies reactive 
astrogliosis allowing robust axonal regeneration through Schwann cell-seeded guidance 
channels after spinal cord injury. Exp Neurol 229(2): 238-50, 2011. 
 95 
 
35. Olson HE, Rooney GE, Gross L, Nesbitt JJ, Galvin KE, Knight A, Chen B, Yaszemski 
MJ, Windebank AJ. Neural stem cell- and Schwann cell-loaded biodegradable polymer 
scaffolds support axonal regeneration in the transected spinal cord. Tissue Eng Part A 
15(7): 1797-805, 2009. 
36. Meijs MF, Timmers L, Pearse DD, Tresco PA, Bates ML, Joosten EA, Bunge MB, 
Oudega M. Basic fibroblast growth factor promotes neuronal survival but not behavioral 
recovery in the transected and Schwann cell implanted rat thoracic spinal cord. J 
Neurotrauma 21(10): 1415-30, 2004. 
37. Cao L, Liu L, Chen ZY, Wang LM, Ye JL, Qiu HY, Lu CL, He C. Olfactory ensheathing 
cells genetically modified to secrete GDNF to promote spinal cord repair. Brain 127(Pt 3): 
535-49, 2004. 
38. Imaizumi T, Lankford KL, Kocsis JD. Transplantation of olfactory ensheathing cells or 
Schwann cells restores rapid and secure conduction across the transected spinal cord. 
Brain Res 854(1-2): 70-8, 2000. 
39. Takami T, Oudega M, Bates ML, Wood PM, Kleitman N, Bunge MB. Schwann cell but 
not olfactory ensheathing glia transplants improve hindlimb locomotor performance in 
the moderately contused adult rat thoracic spinal cord. J Neurosci 22(15): 6670-81, 2002. 
40. Santos-Silva A, Fairless R, Frame MC, Montague P, Smith GM, Toft A, Riddell JS, 
Barnett SC. FGF/heparin differentially regulates Schwann cell and olfactory ensheathing 
cell interactions with astrocytes: a role in astrocytosis. J Neurosci 27(27): 7154-67, 2007. 
41. Bachelin C, Zujovic V, Buchet D, Mallet J, Baron-Van Evercooren A. Ectopic expression 
of polysialylated neural cell adhesion molecule in adult macaque Schwann cells promotes 
their migration and remyelination potential in the central nervous system. Brain 133(Pt 2): 
406-20, 2009. 
42. Saberi H, Moshayedi P, Aghayan HR, Arjmand B, Hosseini SK, Emami-Razavi SH, 
Rahimi-Movaghar V, Raza M, Firouzi M. Treatment of chronic thoracic spinal cord 
injury patients with autologous Schwann cell transplantation: an interim report on safety 
considerations and possible outcomes. Neurosci Lett 443(1): 46-50, 2008. 
43. Tabesh H, Amoabediny G, Nik NS, Heydari M, Yosefifard M, Siadat SO, Mottaghy K. 
The role of biodegradable engineered scaffolds seeded with Schwann cells for spinal cord 
regeneration. Neurochem Int 54(2): 73-83, 2009. 
44. Friedman JA, Windebank AJ, Moore MJ, Spinner RJ, Currier BL, Yaszemski MJ. 
Biodegradable polymer grafts for surgical repair of the injured spinal cord. Neurosurgery 
51(3): 742-51; discussion 751-2, 2002. 
45. Yu LMY, Leipzig ND, Shoichet MS. Promoting neuron adhesion and growth. Materials 
Today 11(5): 36-43, 2008. 
46. Novikova LN, Mosahebi A, Wiberg M, Terenghi G, Kellerth JO, Novikov LN. Alginate 
hydrogel and matrigel as potential cell carriers for neurotransplantation. Journal of 
Biomedical Materials Research Part A 77A(2): 242-252, 2006. 
47. Hyatt AJT, Wang D, Kwok JC, Fawcett JW, Martin KR. Controlled release of 
chondroitinase ABC from fibrin gel reduces the level of inhibitory glycosaminoglycan 
chains in lesioned spinal cord. Journal of Controlled Release 147(1): 24-29, 2010. 
48. Itosaka H, Kuroda S, Shichinohe H, Yasuda H, Yano S, Kamei S, Kawamura R, Hida K, 
Iwasaki Y. Fibrin matrix provides a suitable scaffold for bone marrow stromal cells 
transplanted into injured spinal cord: A novel material for CNS tissue engineering. 
Neuropathology 29(3): 248-257, 2009. 
 96 
 
49. Johnson PJ, Parker SR, Sakiyama-Elbert SE. Controlled Release of Neurotrophin-3 From 
Fibrin-Based Tissue Engineering Scaffolds Enhances Neural Fiber Sprouting Following 
Subacute Spinal Cord Injury. Biotechnology and Bioengineering 104(6): 1207-1214, 
2009. 
50. Taylor SJ, Rosenzweig ES, McDonald JW, Sakiyama-Elbert SE. Delivery of 
neurotrophin-3 from fibrin enhances neuronal fiber sprouting after spinal cord injury. 
Journal of Controlled Release 113(3): 226-235, 2006. 
51. Johnson PJ, Tatara A, McCreedy DA, Shiu A, Sakiyama-Elbert SE. Tissue-engineered 
fibrin scaffolds containing neural progenitors enhance functional recovery in a subacute 
model of SCI. Soft Matter 6(20): 5127-5137, 2010. 
52. Ahmed Z, Underwood S, Brown RA. Nerve guide material made from fibronectin: 
Assessment of in vitro properties. Tissue Engineering 9(2): 219-231, 2003. 
53. King VR, Henseler M, Brown RA, Priestley JV. Mats made from fibronectin support 
oriented growth of axons in the damaged spinal cord of the adult rat. Exp Neurol 182(2): 
383-98, 2003. 
54. King VR, Phillips JB, Hunt-Grubbe H, Brown R, Priestley JV. Characterization of non-
neuronal elements within fibronectin mats implanted into the damaged adult rat spinal 
cord. Biomaterials 27(3): 485-96, 2006. 
55. Harley BA, Spilker MH, Wu JW, Asano K, Hsu HP, Spector M, Yannas IV. Optimal 
degradation rate for collagen chambers used for regeneration of peripheral nerves over 
long gaps. Cells Tissues Organs 176(1-3): 153-65, 2004. 
56. Tsai EC, Dalton PD, Shoichet MS, Tator CH. Matrix inclusion within synthetic hydrogel 
guidance channels improves specific supraspinal and local axonal regeneration after 
complete spinal cord transection. Biomaterials 27(3): 519-33, 2006. 
57. Klapka N, Muller HW. Collagen matrix in spinal cord injury. J Neurotrauma 23(3-4): 
422-35, 2006. 
58. Khaing ZZ, Schmidt CE. Advances in natural biomaterials for nerve tissue repair. 
Neurosci Lett 519(2): 103-14, 2012. 
59. Novak U, Kaye AH. Extracellular matrix and the brain: components and function. J Clin 
Neurosci 7(4): 280-90, 2000. 
60. Nomura H, Zahir T, Kim H, Katayama Y, Kulbatski I, Morshead CM, Shoichet MS, 
Tator CH. Extramedullary chitosan channels promote survival of transplanted neural 
stem and progenitor cells and create a tissue bridge after complete spinal cord transection. 
Tissue Eng Part A 14(5): 649-65, 2008. 
61. Chenite A, Chaput C, Wang D, Combes C, Buschmann MD, Hoemann CD, Leroux JC, 
Atkinson BL, Binette F, Selmani A. Novel injectable neutral solutions of chitosan form 
biodegradable gels in situ. Biomaterials 21(21): 2155-61, 2000. 
62. Crompton KE, Tomas D, Finkelstein DI, Marr M, Forsythe JS, Horne MK. Inflammatory 
response on injection of chitosan/GP to the brain. J Mater Sci Mater Med 17(7): 633-9, 
2006. 
63. Stokols S, Tuszynski MH. Freeze-dried agarose scaffolds with uniaxial channels 
stimulate and guide linear axonal growth following spinal cord injury. Biomaterials 27(3): 
443-51, 2006. 
64. Stokols S, Tuszynski MH. The fabrication and characterization of linearly oriented nerve 
guidance scaffolds for spinal cord injury. Biomaterials 25(27): 5839-46, 2004. 
 97 
 
65. Stokols S, Sakamoto J, Breckon C, Holt T, Weiss J, Tuszynski MH. Templated agarose 
scaffolds support linear axonal regeneration. Tissue Eng 12(10): 2777-87, 2006. 
66. Burd DA, Greco RM, Regauer S, Longaker MT, Siebert JW, Garg HG. Hyaluronan and 
wound healing: a new perspective. Br J Plast Surg 44(8): 579-84, 1991. 
67. Ozgenel GY. Effects of hyaluronic acid on peripheral nerve scarring and regeneration in 
rats. Microsurgery 23(6): 575-81, 2003. 
68. Lee HS, Kim JC. Effect of amniotic fluid in corneal sensitivity and nerve regeneration 
after excimer laser ablation. Cornea 15(5): 517-24, 1996. 
69. Peattie RA, Nayate AP, Firpo MA, Shelby J, Fisher RJ, Prestwich GD. Stimulation of in 
vivo angiogenesis by cytokine-loaded hyaluronic acid hydrogel implants. Biomaterials 
25(14): 2789-98, 2004. 
70. Oohira A, Matsui F, Matsuda M, Shoji R. Developmental change in the 
glycosaminoglycan composition of the rat brain. J Neurochem 47(2): 588-93, 1986. 
71. Meszar Z, Felszeghy S, Veress G, Matesz K, Szekely G, Modis L. Hyaluronan 
accumulates around differentiating neurons in spinal cord of chicken embryos. Brain Res 
Bull 75(2-4): 414-8, 2008. 
72. Seidlits SK, Khaing ZZ, Petersen RR, Nickels JD, Vanscoy JE, Shear JB, Schmidt CE. 
The effects of hyaluronic acid hydrogels with tunable mechanical properties on neural 
progenitor cell differentiation. Biomaterials 31(14): 3930-40, 2010. 
73. Hou S, Xu Q, Tian W, Cui F, Cai Q, Ma J, Lee IS. The repair of brain lesion by 
implantation of hyaluronic acid hydrogels modified with laminin. J Neurosci Methods 
148(1): 60-70, 2005. 
74. Tian WM, Hou SP, Ma J, Zhang CL, Xu QY, Lee IS, Li HD, Spector M, Cui FZ. 
Hyaluronic acid-poly-D-lysine-based three-dimensional hydrogel for traumatic brain 
injury. Tissue Eng 11(3-4): 513-25, 2005. 
75. Tian WM, Zhang CL, Hou SP, Yu X, Cui FZ, Xu QY, Sheng SL, Cui H, Li HD. 
Hyaluronic acid hydrogel as Nogo-66 receptor antibody delivery system for the repairing 
of injured rat brain: in vitro. J Control Release 102(1): 13-22, 2005. 
76. Wei YT, He Y, Xu CL, Wang Y, Liu BF, Wang XM, Sun XD, Cui FZ, Xu QY. 
Hyaluronic acid hydrogel modified with nogo-66 receptor antibody and poly-L-lysine to 
promote axon regrowth after spinal cord injury. J Biomed Mater Res B Appl Biomater 
95(1): 110-7, 2010. 
77. Horn EM, Beaumont M, Shu XZ, Harvey A, Prestwich GD, Horn KM, Gibson AR, Preul 
MC, Panitch A. Influence of cross-linked hyaluronic acid hydrogels on neurite outgrowth 
and recovery from spinal cord injury. J Neurosurg Spine 6(2): 133-40, 2007. 
78. Prestwich GD, Marecak DM, Marecek JF, Vercruysse KP, Ziebell MR. Controlled 
chemical modification of hyaluronic acid: synthesis, applications, and biodegradation of 
hydrazide derivatives. J Control Release 53(1-3): 93-103, 1998. 
79. Nakajima N, Ikada Y. Mechanism of amide formation by carbodiimide for 
bioconjugation in aqueous media. Bioconjug Chem 6(1): 123-30, 1995. 
80. Perets A, Baruch Y, Weisbuch F, Shoshany G, Neufeld G, Cohen S. Enhancing the 
vascularization of three-dimensional porous alginate scaffolds by incorporating 
controlled release basic fibroblast growth factor microspheres. J Biomed Mater Res A 
65(4): 489-97, 2003. 
 98 
 
81. Tobias CA, Dhoot NO, Wheatley MA, Tessler A, Murray M, Fischer I. Grafting of 
encapsulated BDNF-producing fibroblasts into the injured spinal cord without immune 
suppression in adult rats. J Neurotrauma 18(3): 287-301, 2001. 
82. Ashton RS, Banerjee A, Punyani S, Schaffer DV, Kane RS. Scaffolds based on 
degradable alginate hydrogels and poly(lactide-co-glycolide) microspheres for stem cell 
culture. Biomaterials 28(36): 5518-25, 2007. 
83. Suzuki K, Suzuki Y, Ohnishi K, Endo K, Tanihara M, Nishimura Y. Regeneration of 
transected spinal cord in young adult rats using freeze-dried alginate gel. Neuroreport 
10(14): 2891-4, 1999. 
84. Suzuki Y, Kitaura M, Wu S, Kataoka K, Suzuki K, Endo K, Nishimura Y, Ide C. 
Electrophysiological and horseradish peroxidase-tracing studies of nerve regeneration 
through alginate-filled gap in adult rat spinal cord. Neurosci Lett 318(3): 121-4, 2002. 
85. Prang P, Muller R, Eljaouhari A, Heckmann K, Kunz W, Weber T, Faber C, Vroemen M, 
Bogdahn U, Weidner N. The promotion of oriented axonal regrowth in the injured spinal 
cord by alginate-based anisotropic capillary hydrogels. Biomaterials 27(19): 3560-9, 
2006. 
86. Mosahebi A, Simon M, Wiberg M, Terenghi G. A novel use of alginate hydrogel as 
Schwann cell matrix. Tissue Eng 7(5): 525-34, 2001. 
87. Murugan R, Ramakrishna S. Design strategies of tissue engineering scaffolds with 
controlled fiber orientation. Tissue Eng 13(8): 1845-66, 2007. 
88. Leong KF, Cheah CM, Chua CK. Solid freeform fabrication of three-dimensional 
scaffolds for engineering replacement tissues and organs. Biomaterials 24(13): 2363-78, 
2003. 
89. Hollister SJ. Porous scaffold design for tissue engineering. Nat Mater 4(7): 518-24, 2005. 
90. Hutmacher DW, Sittinger M, Risbud MV. Scaffold-based tissue engineering: rationale 
for computer-aided design and solid free-form fabrication systems. Trends Biotechnol 
22(7): 354-62, 2004. 
91. Hejcl A, Lesny P, Pradny M, Michalek J, Jendelova P, Stulik J, Sykova E. Biocompatible 
hydrogels in spinal cord injury repair. Physiol Res 57 Suppl 3: S121-32, 2008. 
92. Keselowsky BG, Collard DM, Garcia AJ. Integrin binding specificity regulates 
biomaterial surface chemistry effects on cell differentiation. Proc Natl Acad Sci U S A 
102(17): 5953-7, 2005. 
93. Keselowsky BG, Collard DM, Garcia AJ. Surface chemistry modulates focal adhesion 
composition and signaling through changes in integrin binding. Biomaterials 25(28): 
5947-54, 2004. 
94. Ren YJ, Zhang H, Huang H, Wang XM, Zhou ZY, Cui FZ, An YH. In vitro behavior of 
neural stem cells in response to different chemical functional groups. Biomaterials 30(6): 
1036-44, 2009. 
95. Reichardt LF, Tomaselli KJ. Extracellular matrix molecules and their receptors: functions 
in neural development. Annu Rev Neurosci 14: 531-70, 1991. 
96. Frampton JP, Hynd MR, Shuler ML, Shain W. Fabrication and optimization of alginate 
hydrogel constructs for use in 3D neural cell culture. Biomed Mater 6(1): 015002-015019, 
2011. 
97. Suzuki M, Itoh S, Yamaguchi I, Takakuda K, Kobayashi H, Shinomiya K, Tanaka J. 
Tendon chitosan tubes covalently coupled with synthesized laminin peptides facilitate 
nerve regeneration in vivo. J Neurosci Res 72(5): 646-59, 2003. 
 99 
 
98. Cui FZ, Tian WM, Hou SP, Xu QY, Lee IS. Hyaluronic acid hydrogel immobilized with 
RGD peptides for brain tissue engineering. J Mater Sci Mater Med 17(12): 1393-401, 
2006. 
99. Koh HS, Yong T, Chan CK, Ramakrishna S. Enhancement of neurite outgrowth using 
nano-structured scaffolds coupled with laminin. Biomaterials 29(26): 3574-82, 2008. 
100. Dhoot NO, Tobias CA, Fischer I, Wheatley MA. Peptide-modified alginate surfaces as a 
growth permissive substrate for neurite outgrowth. J Biomed Mater Res A 71(2): 191-200, 
2004. 
101. Hashemi SM, Soudi S, Shabani I, Naderi M, Soleimani M. The promotion of stemness 
and pluripotency following feeder-free culture of embryonic stem cells on collagen-
grafted 3-dimensional nanofibrous scaffold. Biomaterials 32(30): 7363-74, 2011. 
102. Li W, Guo Y, Wang H, Shi D, Liang C, Ye Z, Qing F, Gong J. Electrospun nanofibers 
immobilized with collagen for neural stem cells culture. J Mater Sci Mater Med 19(2): 
847-54, 2008. 
103. Prabhakaran MP, Venugopal JR, Ramakrishna S. Mesenchymal stem cell differentiation 
to neuronal cells on electrospun nanofibrous substrates for nerve tissue engineering. 
Biomaterials 30(28): 4996-5003, 2009. 
104. He J, Wang XM, Spector M, Cui FZ. Scaffolds for central nervous system tissue 
engineering Frontiers of Materials Science 6(1): 1-25, 2012. 
105. Georges PC, Miller WJ, Meaney DF, Sawyer ES, Janmey PA. Matrices with compliance 
comparable to that of brain tissue select neuronal over glial growth in mixed cortical 
cultures. Biophys J 90(8): 3012-8, 2006. 
106. Woerly S, Doan VD, Sosa N, de Vellis J, Espinosa-Jeffrey A. Prevention of gliotic scar 
formation by NeuroGel allows partial endogenous repair of transected cat spinal cord. J 
Neurosci Res 75(2): 262-72, 2004. 
107. Oakland RJ, Hall RM, Wilcox RK, Barton DC. The biomechanical response of spinal 
cord tissue to uniaxial loading. Proc Inst Mech Eng H 220(4): 489-92, 2006. 
108. Ozawa H, Matsumoto T, Ohashi T, Sato M, Kokubun S. Comparison of spinal cord gray 
matter and white matter softness: measurement by pipette aspiration method. J Neurosurg 
95(2 Suppl): 221-4, 2001. 
109. Straley KS, Foo CW, Heilshorn SC. Biomaterial design strategies for the treatment of 
spinal cord injuries. J Neurotrauma 27(1): 1-19, 2009. 
110. Yao L, de Ruiter GC, Wang H, Knight AM, Spinner RJ, Yaszemski MJ, Windebank AJ, 
Pandit A. Controlling dispersion of axonal regeneration using a multichannel collagen 
nerve conduit. Biomaterials 31(22): 5789-97, 2010. 
111. Gros T, Sakamoto JS, Blesch A, Havton LA, Tuszynski MH. Regeneration of long-tract 
axons through sites of spinal cord injury using templated agarose scaffolds. Biomaterials 
31(26): 6719-29, 2010. 
112. Wong DY, Leveque JC, Brumblay H, Krebsbach PH, Hollister SJ, Lamarca F. Macro-
architectures in spinal cord scaffold implants influence regeneration. J Neurotrauma 
25(8): 1027-37, 2008. 
113. Suri S, Han LH, Zhang W, Singh A, Chen S, Schmidt CE. Solid freeform fabrication of 
designer scaffolds of hyaluronic acid for nerve tissue engineering. Biomed Microdevices 
13(6): 983-93, 2011. 
 100 
 
114. Kim YT, Haftel VK, Kumar S, Bellamkonda RV. The role of aligned polymer fiber-
based constructs in the bridging of long peripheral nerve gaps. Biomaterials 29(21): 
3117-27, 2008. 
115. Bozkurt A, Brook GA, Moellers S, Lassner F, Sellhaus B, Weis J, Woeltje M, Tank J, 
Beckmann C, Fuchs P, Damink LO, Schugner F, Heschel I, Pallua N. In vitro assessment 
of axonal growth using dorsal root ganglia explants in a novel three-dimensional collagen 
matrix. Tissue Eng 13(12): 2971-9, 2007. 
116. Bozkurt A, Deumens R, Beckmann C, Olde Damink L, Schugner F, Heschel I, Sellhaus 
B, Weis J, Jahnen-Dechent W, Brook GA, Pallua N. In vitro cell alignment obtained with 
a Schwann cell enriched microstructured nerve guide with longitudinal guidance channels. 
Biomaterials 30(2): 169-79, 2009. 
117. Goldner JS, Bruder JM, Li G, Gazzola D, Hoffman-Kim D. Neurite bridging across 
micropatterned grooves. Biomaterials 27(3): 460-72, 2006. 
118. Xie J, MacEwan MR, Li X, Sakiyama-Elbert SE, Xia Y. Neurite outgrowth on nanofiber 
scaffolds with different orders, structures, and surface properties. ACS Nano 3(5): 1151-9, 
2009. 
119. Corey JM, Lin DY, Mycek KB, Chen Q, Samuel S, Feldman EL, Martin DC. Aligned 
electrospun nanofibers specify the direction of dorsal root ganglia neurite growth. J 
Biomed Mater Res A 83(3): 636-45, 2007. 
120. Cho YI, Choi JS, Jeong SY, Yoo HS. Nerve growth factor (NGF)-conjugated electrospun 
nanostructures with topographical cues for neuronal differentiation of mesenchymal stem 
cells. Acta Biomater 6(12): 4725-33, 2010. 
121. Xie J, Willerth SM, Li X, Macewan MR, Rader A, Sakiyama-Elbert SE, Xia Y. The 
differentiation of embryonic stem cells seeded on electrospun nanofibers into neural 
lineages. Biomaterials 30(3): 354-62, 2009. 
122. Wang Y, Yao M, Zhou J, Zheng W, Zhou C, Dong D, Liu Y, Teng Z, Jiang Y, Wei G, 
Cui X. The promotion of neural progenitor cells proliferation by aligned and randomly 
oriented collagen nanofibers through beta1 integrin/MAPK signaling pathway. 
Biomaterials 32(28): 6737-44, 2011. 
123. Mironov V, Trusk T, Kasyanov V, Little S, Swaja R, Markwald R. Biofabrication: a 21st 
century manufacturing paradigm. Biofabrication 1(2): 022001, 2009. 
124. De Laporte L, Yang Y, Zelivyanskaya ML, Cummings BJ, Anderson AJ, Shea LD. 
Plasmid releasing multiple channel bridges for transgene expression after spinal cord 
injury. Mol Ther 17(2): 318-26, 2009. 
125. Teng YD, Lavik EB, Qu X, Park KI, Ourednik J, Zurakowski D, Langer R, Snyder EY. 
Functional recovery following traumatic spinal cord injury mediated by a unique polymer 
scaffold seeded with neural stem cells. Proc Natl Acad Sci U S A 99(5): 3024-9, 2002. 
126. Gautier SE, Oudega M, Fragoso M, Chapon P, Plant GW, Bunge MB, Parel JM. 
Poly(alpha-hydroxyacids) for application in the spinal cord: resorbability and 
biocompatibility with adult rat Schwann cells and spinal cord. J Biomed Mater Res 42(4): 
642-54, 1998. 
127. Sachlos E, Czernuszka JT. Making tissue engineering scaffolds work. Review: the 
application of solid freeform fabrication technology to the production of tissue 
engineering scaffolds. Eur Cell Mater 5(29-39; discussion 39-40, 2003. 
 101 
 
128. Malda J, Woodfield TB, van der Vloodt F, Wilson C, Martens DE, Tramper J, van 
Blitterswijk CA, Riesle J. The effect of PEGT/PBT scaffold architecture on the 
composition of tissue engineered cartilage. Biomaterials 26(1): 63-72, 2005. 
129. Silva NA, Salgado AJ, Sousa RA, Oliveira JT, Pedro AJ, Leite-Almeida H, Cerqueira R, 
Almeida A, Mastronardi F, Mano JF, Neves NM, Sousa N, Reis RL. Development and 
characterization of a novel hybrid tissue engineering-based scaffold for spinal cord injury 
repair. Tissue Eng Part A 16(1): 45-54, 2009. 
130. Woodfield TBF, Malda J, de Wijn J, Peters F, Riesle J, van Blitterswijk CA. Design of 
porous scaffolds for cartilage tissue engineering using a three-dimensional fiber-
deposition technique. Biomaterials 25(18): 4149-4161, 2004. 
131. Vozzi G, Previti A, De Rossi D, Ahluwalia A. Microsyringe-based deposition of two-
dimensional and three-dimensional polymer scaffolds with a well-defined geometry for 
application to tissue engineering. Tissue Engineering 8(6): 1089-1098, 2002. 
132. Chen XB. Modeling of rotary screw fluid dispensing processes. Journal of Electronic 
Packaging 129(2): 172-178, 2007. 
133. Chen XB, Li MG, Ke H. Modeling of the flow rate in the dispensing-based process for 
fabricating tissue scaffolds. Journal of Manufacturing Science and Engineering-
Transactions of the Asme 130(2): 020601.1-024503.5 2008. 
134. Li MG, Tian XY, Chen XB. Modeling of Flow Rate, Pore Size, and Porosity for the 
Dispensing-Based Tissue Scaffolds Fabrication. Journal of Manufacturing Science and 
Engineering-Transactions of the Asme 131(3): 034501-5, 2009. 
135. Haug A, Larsen B. Solubility of Alginate at Low Ph. Acta Chemica Scandinavica 17(6): 
1653-62, 1963. 
136. Danishef.I, Siskovic E. Conversion of Carboxyl Groups of Mucopolysaccharides into 
Amides of Amino Acid Esters. Carbohydrate Research 16(1): 199-205, 1971. 
137. Leach JB, Bivens KA, Collins CN, Schmidt CE. Development of photocrosslinkable 
hyaluronic acid-polyethylene glycol-peptide composite hydrogels for soft tissue 
engineering. J Biomed Mater Res A 70(1): 74-82, 2004. 
138. Mosmann T. Rapid colorimetric assay for cellular growth and survival: application to 
proliferation and cytotoxicity assays. J Immunol Methods 65(1-2): 55-63, 1983. 
139. Estes JM, Adzick NS, Harrison MR, Longaker MT, Stern R. Hyaluronate metabolism 
undergoes an ontogenic transition during fetal development: implications for scar-free 
wound healing. J Pediatr Surg 28(10): 1227-31, 1993. 
140. Wiig M, Abrahamsson SO, Lundborg G. Effects of hyaluronan on cell proliferation and 
collagen synthesis: a study of rabbit flexor tendons in vitro. J Hand Surg Am 21(4): 599-
604, 1996. 
141. Khalil S, Nam J, Sun W. Multi-nozzle deposition for construction of 3D biopolymer 
tissue scaffolds. Rapid Prototyping Journal 11(1): 9-17, 2005. 
142. Bakshi A, Fisher O, Dagci T, Himes BT, Fischer I, Lowman A. Mechanically engineered 
hydrogel scaffolds for axonal growth and angiogenesis after transplantation in spinal cord 
injury. J Neurosurg Spine 1(3): 322-9, 2004. 
143. Sparrey CJ, Keaveny TM. Compression behavior of porcine spinal cord white matter. J 
Biomech 44(6): 1078-82, 2011. 
144. Man AJ, Davis HE, Itoh A, Leach JK, Bannerman P. Neurite outgrowth in fibrin gels is 
regulated by substrate stiffness. Tissue Eng Part A 17(23-24): 2931-42, 2011. 
 102 
 
145. Scott R, Marquardt L, Willits RK. Characterization of poly(ethylene glycol) gels with 
added collagen for neural tissue engineering. J Biomed Mater Res A 93(3): 817-23, 2010. 
146. Engler AJ, Sen S, Sweeney HL, Discher DE. Matrix elasticity directs stem cell lineage 
specification. Cell 126(4): 677-89, 2006. 
147. Khaing ZZ, Milman BD, Vanscoy JE, Seidlits SK, Grill RJ, Schmidt CE. High molecular 
weight hyaluronic acid limits astrocyte activation and scar formation after spinal cord 
injury. J Neural Eng 8(4): 046033-44, 2011. 
148. Struve J, Maher PC, Li YQ, Kinney S, Fehlings MG, Kuntz Ct, Sherman LS. Disruption 
of the hyaluronan-based extracellular matrix in spinal cord promotes astrocyte 
proliferation. Glia 52(1): 16-24, 2005. 
149. Bourguignon LY, Peyrollier K, Gilad E, Brightman A. Hyaluronan-CD44 interaction 
with neural Wiskott-Aldrich syndrome protein (N-WASP) promotes actin polymerization 
and ErbB2 activation leading to beta-catenin nuclear translocation, transcriptional up-
regulation, and cell migration in ovarian tumor cells. J Biol Chem 282(2): 1265-80, 2007. 
150. Rowley JA, Madlambayan G, Mooney DJ. Alginate hydrogels as synthetic extracellular 
matrix materials. Biomaterials 20(1): 45-53, 1999. 
151. Pouyani T, Prestwich GD. Functionalized derivatives of hyaluronic acid oligosaccharides: 
drug carriers and novel biomaterials. Bioconjug Chem 5(4): 339-47, 1994. 
152. Sherman L, Skroch-Angel P, Moll J, Schwechheimer K, Ponta H, Herrlich P, Hofmann 
M. Schwann cell tumors express characteristic patterns of CD44 splice variants. J 
Neurooncol 26(3): 171-84, 1995. 
153. Maharjan AS, Pilling D, Gomer RH. High and low molecular weight hyaluronic acid 
differentially regulate human fibrocyte differentiation. PLoS One 6(10): e26078-87, 2011. 
154. Suri S, Schmidt CE. Cell-laden hydrogel constructs of hyaluronic acid, collagen, and 
laminin for neural tissue engineering. Tissue Eng Part A 16(5): 1703-16, 2010. 
155. Shu XZ, Ghosh K, Liu Y, Palumbo FS, Luo Y, Clark RA, Prestwich GD. Attachment and 
spreading of fibroblasts on an RGD peptide-modified injectable hyaluronan hydrogel. J 
Biomed Mater Res A 68(2): 365-75, 2004. 
156. Brannvall K, Bergman K, Wallenquist U, Svahn S, Bowden T, Hilborn J, Forsberg-
Nilsson K. Enhanced neuronal differentiation in a three-dimensional collagen-hyaluronan 
matrix. J Neurosci Res 85(10): 2138-46, 2007. 
157. Deister C, Aljabari S, Schmidt CE. Effects of collagen 1, fibronectin, laminin and 
hyaluronic acid concentration in multi-component gels on neurite extension. J Biomater 
Sci Polym Ed 18(8): 983-97, 2007. 
158. Zhang H, Wei YT, Tsang KS, Sun CR, Li J, Huang H, Cui FZ, An YH. Implantation of 
neural stem cells embedded in hyaluronic acid and collagen composite conduit promotes 
regeneration in a rabbit facial nerve injury model. J Transl Med 6(1): 67-77, 2008. 
159. Genes NG, Rowley JA, Mooney DJ, Bonassar LJ. Effect of substrate mechanics on 
chondrocyte adhesion to modified alginate surfaces. Arch Biochem Biophys 422(2): 161-
7, 2004. 
160. Lee CR, Grodzinsky AJ, Spector M. The effects of cross-linking of collagen-
glycosaminoglycan scaffolds on compressive stiffness, chondrocyte-mediated contraction, 
proliferation and biosynthesis. Biomaterials 22(23): 3145-54, 2001. 
161. Subramanian A, Lin HY. Crosslinked chitosan: its physical properties and the effects of 
matrix stiffness on chondrocyte cell morphology and proliferation. J Biomed Mater Res 
A 75(3): 742-53, 2005. 
 103 
 
162. Cao N. Fabrication of Alginate Hydrogel Scaffolds and Cell Viability in Calcium-
Crosslinked Alginate Hydrogel. Division of Biomedical Engineering, Master of Science, 
Saskatoon, University of Saskatchewan, 1-83, 2011. 
 
 
 
